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ABSTRACT
Sleep problems can have a broad impact across the day-to-day functioning of an 
individual. Persons with intellectual disabilities are at a particular risk for developing sleep 
problems, with prevalence estimates much higher than is found in the general population. 
Nonetheless, the assessment of sleep problems in persons with intellectual disabilities has been 
widely overlooked. The Sleep Problems Inventory (SLEEPY) was created to measure various 
factors related to sleep problems in persons with intellectual disabilities. The present study 
represents the first steps in establishing the reliability and validity of the SLEEPY in adults with 
intellectual disabilities.
1INTRODUCTION
Sleep has a broad effect across many of the day-to-day aspects of an individual’s life. 
Because of the many areas that sleep impacts, these problems can disrupt the functioning of an 
individual in many domains. Thus, sleep problems can serve to exacerbate minor difficulties or 
irritations (Schreck, Mulick, & Smith, 2004). However, while sleep problems can lead to day-to-
day difficulties and disorders, they are not necessarily the primary cause. In many instances the 
sleep problem is a result of a medical condition, side effect of medication, poor sleep hygiene, or 
a psychological disorder (Benca, 2000; Gillin & Drummond, 2000; Smith, Smith, Nowakowski, 
& Perlis, 2003; Uhde, 2000). A large number of disorders in the DSM-IV-TR (APA, 2000) 
include sleep problems among the diagnostic criteria.
Sleep problems are a common occurrence. Most people will have a sleep problem at one 
point in their life, which will go away after a short duration and cause little disruption. However, 
the prevalence of more significant and longstanding sleep problems is estimated between 5% and 
15%  (Ford & Kamerow, 1989; Mellinger, Balter, & Uhlenhuth, 1985; Ohayon, Caulet, Philip, 
Guilleminault, & Priest, 1997). A significant relationship exists between sleep and psychological 
functioning. Sleep disorders are often associated with emotional disorders or stressful life events 
(Ford & Kamerow, 1989). Likewise, patients with chronic sleep disorders have been found to be 
at an increased risk for depression, anxiety disorders, substance abuse disorders, and nicotine 
dependence (Breslau, Roth, Rosenthal, & Andreski, P., 1996; Ford & Kamerow, 1989). 
Improvements in mood may often be found when treating the underlying sleep problem (Jacobs, 
Benson, & Friedman, 1993; Jacobs, Pace-Schott, Stickgold, & Otto, 2004). Because of the 
diverse areas that sleep impacts, an increased knowledge of the assessment and treatment of 
2sleep problems has significant potential to aid a myriad of health professionals in assisting their 
clients.
In an effort to increase the clinician’s ability to identify and diagnose sleep disorders, a 
number of assessment methods have been developed, including polysomnography, actigraphy, 
and questionnaires. Two of the most frequently used questionnaires are the Epsworth Sleepiness 
Scale (Johns, 1991) and the Stanford Sleepiness Scale (Hoddes, Dement, & Zarcone, 1972). The 
efforts to develop more reliable and valid assessment measures have for the most part been 
successful and have shown adequate psychometric properties (Herscovitch & Broughton, 1981; 
Johns, 1994). Nonetheless, the assessment of sleep problems in persons with intellectual 
disabilities has been widely overlooked. Few measures have been constructed to assess for sleep 
disorders in adults with intellectual disabilities and only one measure, the Behavior Evaluation of 
Disorders of Sleep (BEDS; Schreck, 1997/1998), has been constructed to assess for sleep 
disorders in children with intellectual disabilities. A questionnaire by Simonds and Parraga 
(1984) has been used in modified forms across a number of studies in persons with intellectual 
disabilities (e.g. Brylewski & Wiggs, 1999; Didden, Korzilius, van Aperlo, van Overloop & de 
Vries, 2002; Wiggs & Stores, 1996). However, only one study addressed the psychometric 
properties of this questionnaire (Hunt & Stores, 1994). One other tool that has been developed to 
assess for sleep problems in persons with developmental disabilities is the Diagnostic 
Assessment for the Severely Handicapped (DASH-II; Matson, 1993). The DASH-II is an 
informant based screening tool for the rapid assessment of psychopathology in persons with 
developmental disabilities. The DASH-II contains a sleep disorders subscale consisting of 5 
items. Initial evaluation of the psychometric properties of the sleep subscale are favorable. 
3However, in line with the overall purpose of screening for a broad spectrum of psychopathology, 
the item content of the DASH-II sleep scale is limited.
The paucity of assessment measures for sleep disorders in persons with intellectual 
disabilities is most striking when considering the prevalence of reported sleep problems in this 
population, which are estimated at 23% to 51% (Bartlett, Roney, & Spedding, 1985; Quine, 
1991). Johnson (1996) notes that the relative lack of research on sleep disorders in persons with 
intellectual disabilities may be due partially to a lack of valid and reliable assessment measures 
designed for use in this population. However, whatever the reason, there is no debate about the 
fact that little attention has been paid to sleep irregularities as applied especially to persons with 
severe and profound mental retardation.
The present study represents the first step in establishing a measure to assess for sleep 
problems in adults with intellectual disabilities. While the sleep subscale of the DASH-II may be 
useful to identify potential problems with sleep as a part of a larger evaluation, a more in depth 
assessment of sleep problems containing a broader content (e.g., breathing related sleep 
problems) would do much to advance research and treatment of sleep problems in persons with 
developmental disabilities. The Sleep Problems Inventory (SLEEPY) was created to measure 
various factors related to sleep disorders in persons with intellectual disabilities, a little explored 
area. An important first step in establishing acceptable psychometric properties of this measure is 
examining the SLEEPY’s factor structure, reliability, and validity.
4REVIEW OF LITERATURE
Sleep Disorders
Assessment of Sleep
Sleep has been a topic of philosophical musing since early history. However, it was only 
in the last century that the study of sleep emerged as a serious scientific endeavor (Dement, 
2000). The advent of sleep as a topic of scientific inquiry can be dated to 1930, when Hans 
Berger demonstrated that the sleeping brain produced electrical rhythms that were distinct from 
the rhythms produced while awake (Berger, 1930). Berger titled the electrical recordings 
“electroencephalograms” (EEG), and thus a method to measure and study activity in the sleeping 
brain emerged. The sophistication of EEG methods has improved dramatically since its inception 
and it still remains a major component of polysomnography (PSG), the gold standard for 
establishing the presence of a sleep disorder (Smith, Nowakowski, Soeffing, Orff, & Perlis, 
2003). There are primarily four ways that sleep is assessed. They include PSG, actigraphy, direct 
observation, and self-report (questionnaires, sleep diaries, etc.). 
When used for measuring sleep, PSG consists of three measures, EEG, electromyography 
(EMG), and electrooculography (EOG) (Smith, et al., 2003). All three measures are indices of 
electrical activity produced by their respective locations (scalp, muscles, and eyes). While EEG 
is the primary measure, EMG and EOG are useful in determining sleep stage (such as REM 
sleep). When combined with other measures of cardiac, respiratory, and peripheral nervous 
system activity, the PSG becomes a very sensitive tool for diagnosing various dyssomnias and 
parasomnias (Smith et al., 2003). However, PSG is cumbersome and is almost exclusively 
conducted in a laboratory environment, yet technology continues to improve as new 
advancements have been integrated into the process. Efforts to develop portable and less 
intrusive devices for PSG have begun to receive the attention of researchers (Chervin, 2000); 
5however, entirely different ways of measuring sleep such as actigraphy have also been developed 
as a means to overcome the cumbersomeness of PSG.
Actigraphy is a useful but often underused measure of sleep (Ancoli-Israel, Cole, Alessi, 
Chambers, Moorcroft, & Pollak, 2003; Smith, et al., 2003). Simply put, actigraphy is a 
measurement of activity summated over a number of time intervals. It is assumed that although 
movement may occur while sleeping or the individual may be inactive while awake, that overall, 
activity indicates wakefulness and inactivity indicates sleep. In studies with humans, the 
actigraph is usually worn on the wrist, similar to a wristwatch. One benefit of the actigraph over 
PSG is its portability. While early models have been somewhat obtrusive, newer models are 
smaller and may be disguised in the shape of a wristwatch to decrease the awkwardness of 
wearing the device in day-to-day circumstances. In a critical review of the methodological issues 
with actigraphy, Tryon (2004) concluded that while studies have found that PSG and actigraphy 
do not relate well, this variability is not random, but systematic and controllable. Further, Tryon 
(2004) points out that the reliability coefficients meet or exceed those of commonly used medical 
or psychological tests. Ancoli-Israel et al. (2003) concluded that actigraphy is a moderately valid 
and reliable means to differentiate sleep states but becomes less reliable as the severity of sleep 
problems increase. Further, Ancoli-Israel et al. (2003) commented that while actigraphy is less 
reliable, it can be used in situations where PSG is not practical. Nonetheless, there remains much 
that still needs to be done to validate the use of actigraphy to measure sleep problems.
Direct observations are commonly used in residential and inpatient settings. This 
procedure consists of monitoring an individual for the presence of sleep over a series of intervals. 
Observable definitions of sleep must be clearly stated as well as the rate of intervals. For the data 
to show meaningful changes, the intervals should be 30 minutes or less. However, Smith et al. 
6(2003) point out that as the time between intervals decreases, the compliance and vigilance of 
direct care staff to reliably observe the individual may decrease. Further, error may be introduced 
by poorly defined target behaviors. Nonetheless, this procedure is inexpensive and easy to 
implement. Moreover, adequate training as well as explicit behavioral definitions of the target 
behaviors may control much of the unreliability.
Self-report measures are a mainstay of clinical sleep assessment (Smith et al., 2003). 
These assessments may vary from informal questions about sleep quality to validated scales. 
While commonly used, self-report measures have a number of problems with validity that 
depend upon the particular aspects of the measure used. For instance, retrospective measures and 
prospective measures like sleep logs depend upon the ability of the individual to report 
accurately (Smith et al., 2003). A number of factors may influence the individual’s recall on such 
scales including primacy, recency, and confirmation bias. Further, they depend upon how well 
the individual can average their sleeping behavior across a number of days and report on their 
“overall” sleep. Prospective measures such as sleep diaries are not as dependent upon an 
individual’s long-term memory or the ability to summate their sleep. However, sleep diaries 
commonly ask the individual to rate things such as how long it took them to fall asleep. Whether 
an individual can answer such items accurately is questionable (Smith et al., 2003). While these 
limitations are significant, self-report measures still provide useful and valid information if 
constructed properly and used in the appropriate context (Smith et al., 2003).
The methods used to assess for particular sleep disorders is highly dependent upon the 
disorder in question. For example, the diagnostic tools to evaluate for insomnia will differ greatly 
from those used in obstructive sleep apnea. PSG may continue to be the gold standard for 
diagnosing a sleep disorder (Ancoli-Israel et al., 2003). However, this method requires 
7substantial amounts of time and resources. Many sleep disorders may be identified by more 
efficient means such as structured interviews and questionnaires. When available, other methods 
that are more cost effective, less intrusive, and more adaptable to measuring sleep in the natural 
setting may be preferred. 
Classification of Sleep Disorders
The classification of sleep disorders has received a good deal of attention. The two most 
frequently used classification systems are the International Classification of Sleep Disorders 
(ICSD) and the DSM-IV-TR. The ICSD, originally published in 1990 by the American Sleep 
Disorder Association was revised in 2000 with the purpose of updating the ICSD code numbers 
to match the ICD-10 system. The ICSD was published primarily with the goal of expediting 
diagnosis and classification for epidemiological purposes. In spite of the similarities between the 
ICSD and the DSM-IV, there has been much debate over which system ought to be used. 
Because of the greater number of subdivisions and categories in the ICSD, many sleep-
specialists prefer this nosology (Thorpy, 2000). However, while useful for diagnosis or 
epidemiological information, this degree of subdivision is not usually found in the research 
literature. Instead, more general terms are often employed. 
In the ICSD system, the disorders are broken down into four categories: (1) dyssomnias; 
(2) parasomnias; (3) sleep disorders associated with mental, neurologic, or other medical 
disorders; and (4) proposed sleep disorders, disorders with insufficient data to show clear 
diagnostic guidelines (American Academy of Sleep Medicine, 2000). The ICSD results in 84 
distinguishable sleep disorders. 
The DSM-IV-TR categories include: (1) Primary Sleep Disorders, which is broken down 
into dyssomnias and parasomnias; (2) sleep disorders related to another mental disorder; (3) 
8sleep disorders due to a general medical condition; and (4) substance-induced sleep disorder. 
While the two classification systems are divided differently, many of the same disorders are 
included in both, but are simply classified into different sections. While developers of both 
systems attempt to organize the disorders based upon known etiology, they have arrived at 
different outcomes. This development may be due in part to efforts to match the ICSD’s coding 
system to that of the ICD.
Regardless of classification system, historically, sleep disorders not due to a substance or 
medical condition are separated into two categories: dyssomnias and parasomnias. The 
dyssomnias consist of problems related directly to the sleep process (i.e. amount, quality, and 
timing of sleep). The parasomnias consist of problems that occur during sleep or sleep-wake 
transitions. According to the DSM-IV-TR (APA, 2000) the dyssomnias include Primary 
Insomnia, Primary Hypersomnia, Narcolepsy, Breathing-Related Sleep Disorder, Circadian 
Rhythm Sleep Disorder, and Dyssomnia Not Otherwise Specified. The parasomnias include 
Nightmare Disorder, Sleep Terror Disorder, Sleepwalking Disorder, and Parasomnia Not 
Otherwise Specified. A detailed discussion of each sleep disorder is beyond the scope of this 
paper, particularly in light of the high differentiation in the ICSD; however, they will be covered 
generally, with emphasis on the disorders recognized by both the DSM-IV-TR and ICSD.
Dyssomnias
Insomnia 
Insomnia is one of the most common sleep disorders. Depending on the definition used, 
prevalence estimates vary from 10-50% (Zorick & Walsh, 2000). Most conservative estimates 
fall around 10% in a six month time period (Ford & Kamerow, 1989; Simon & VonKorff, 1997). 
In persons between 20 and 40 years of age, prevalence estimates do not vary by gender. 
9However, in persons over 65 years of age, women are more likely to have problems with 
insomnia than men (Zorick & Walsh, 2000). Further, persons over 65 are in general more likely 
to experience problems with insomnia than younger adults (Ganguli, Reynolds, & Gilby, 1996). 
Children and adolescents are also more susceptible to having problems with insomnia, with 
children 6-24 months old having prevalence rates of 20-30% (Lozoff, Wolf, Davis, 1985; 
Richman, 1981). From the ages of 4-8 these rates decrease to approximately 15% (Zorick & 
Walsh, 2000). These data suggest that prevalence rates of insomnia follow a developmental 
course in which persons in early childhood and older adulthood are more likely to experience 
this problem.
A number of environmental, psychological, and medical factors may cause or lead to 
insomnia. Factors rarely occur singularly; rather, they occur in concert with one another. For 
example, Parkinson’s disease may cause insomnia (Garcia-Borreguero, Larrosa, & Bravo, 2003). 
However, individuals dealing with this medical condition also often experience anxiety and 
depression, both of which are known to contribute to problems with insomnia. For diagnostic and 
treatment purposes, teasing apart the various factors contributing to the insomnia is complex and 
difficult.
For cases in which insomnia occurs in the absence of psychological, environmental, and 
medical problems, the insomnia is considered to be free-standing and thus is seen as a root 
problem rather than a symptom of another disorder (Hauri, 2000). The DSM-IV-TR classifies 
these cases as Primary Insomnia. The ICSD has three classifications for free-standing insomnia: 
psychophysiological insomnia, sleep-state misperception, and idiopathic insomnia.
Compelling evidence is available to suggest that primary insomnia is fundamentally 
different from other forms of insomnia in which sleep deprivation is imposed on the individual 
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as a result of some other disorder. The most significant difference is that persons with primary 
insomnia appear to be hyperaroused (Hauri, 2000). Likewise, Bonnet and Arand (1995) have 
shown that persons with insomnia more closely resemble hyperarousal than sleep deprivation.
Because of the many different causes for insomnia, the assessment process must be 
broad. Insomnia is most commonly diagnosed by history alone (American Sleep Disorder 
Association, 1995; Chervin, 2000; Reite, Buysse, Reynolds, & Mendelson, 1996). PSG, 
actigraphy, self report, and direct observations may also all be employed to determine the 
severity of the insomnia even though not necessary to determine the actual presence of the 
disorder (Chervin, 2000). The diagnostic process becomes more complicated though when 
attempting to determine the etiology of the insomnia. In doing so, many other domains need to 
be assessed, including both psychiatric and medical causes. PSG is useful to assess for physical 
abnormalities such as BRSD. However, the cause may often simply be inadequate sleep hygiene. 
Chervin (2000) points out that PSG should not be overused as it may convince the patient that 
the cause of the insomnia is biological and undermine attempts to effectively treat the insomnia 
behaviorally.
Insomnia is troublesome and frustrating for many people who experience it frequently. 
However, it is not particularly the inability to fall asleep that is found distressing, but rather it is 
the consequences of getting too little sleep that are seen as the problem. Lack of sleep can 
increase irritability, lead to excessive daytime sleepiness, or impair functioning while at work 
(Zorick & Walsh, 2000). However, these symptoms may be caused by any sleep disorder that 
impairs the amount, quality, or timing of sleep. 
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Hypersomnia
Sleep is often considered a drive state, in much the same way as hunger. As time without 
food increases, hunger also increases and is reduced by food consumption; likewise sleepiness is 
also increased by time without sleep and is reduced by sleeping. However, sleep is not simply a 
singular process of deactivation due to sleep-debt, but rather consists of multiple processes. 
Borbély (1982) originally proposed a two-factor model in which the drive for sleep consists of
homeostatic and circadian-rhythm components. This model has received much support and is 
still widely held (Cluydts, Valck, Verstraeten, & Theys, 2002). Other models have been 
proposed by various researchers, which include three or more factors (Folkard & Åkerstedt, 
1987). However, systems of sleepiness that rely solely upon systems of deactivation may not 
capture the whole picture. A system of two opposing processes controlling the sleep-wake state 
was proposed by Edgar, Dement, and Fuller (1993) in which a drive for sleep consisting of sleep-
debt and deactivating chronobiological factors compete with a drive for wakefulness consisting 
of environmental and activating chronobiological factors. Such a system of various processes 
competing to both activate and deactivate is more in line with the heterogeneity of problems with 
sleep.
For most people, sleepiness will wax and wane throughout the day with a decrease in 
alertness during the mid-afternoon (2:00 pm) and more severely during early morning (2:00 am) 
(Mitler & Miller, 1996). The drop in alertness during the afternoon corresponds to a peak in body 
temperature and the drop in the late evening corresponds with a significant drop in body 
temperature. However, these temperature peaks and drops may vary as there is much 
heterogeneity among individuals (Cluydts et al., 2002). Excessive daytime sleepiness is a 
common complaint. As excessive daytime sleepiness becomes more severe it may lead to mild 
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problems such as inattentiveness or to more serious problems such as motor vehicle accidents. 
Mild cases of excessive daytime sleepiness may simply be due to poor sleep hygiene. However, 
more severe cases of excessive daytime sleepiness are frequently associated with obstructive and 
central sleep apnea, restless leg syndrome, and neurodegenerative diseases (El-Ad & Korczyn, 
1998).
Idiopathic hypersomnia (ICSD) or primary hypersomnia (DSM-IV) consists of 
complaints of severe excessive daytime sleepiness in the presence of normal sleep architecture. 
The diagnosis of idiopathic/primary hypersomnia depends greatly upon the process of ruling out 
other sleep disorders such as narcolepsy or obstructive sleep apnea. Much of the diagnosis of 
hypersomnia relies upon self-reported problems with daytime somnolence. The gold standard for 
measuring daytime sleepiness is the multiple sleep latency test (MSLT; Mitler, Carskadon, & 
Hirshkowitz, 2000). The MSLT consists of a series of naps while undergoing PSG to determine 
how quickly the individual is able to fall asleep. The time until sleep onset is computed as an 
index of the individual’s sleepiness. While self-report has not been found to correlate well with 
MSLT (Chervin, Aldrich, Pickett, & Guilleminault, 1997), measures such as the Stanford 
Sleepiness Scale (Hoddes, et al., 1972) and the Epworth Sleepiness Scale (Johns, 1991) may 
provide more reliable results.
Narcolepsy is essentially defined the same by both the ICSD and DSM-IV-TR. The 
DSM-IV diagnostic criteria include irresistible attacks of refreshing sleep that occur daily over at 
least 3 months and the presence of cataplexy or intrusions of REM sleep during sleep-wake 
transitions (APA, 2000). Recognition of the disorder dates back to 1880 when Gelineau first 
coined the term narcolepsy and described it as short episodes of irresistible sleep that were 
sometimes preceded by falls (Guilleminault & Anagnos, 2000). The disorder was further refined 
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in 1934 by Daniels who developed the cluster of symptoms commonly known as the “narcoleptic 
tetrad.” These five symptoms consisted of daytime sleepiness, cataplexy, sleep paralysis, and 
hypnagogic hallucinations. While substantial progress has been made concerning the etiology of 
the disorder, one can see from the current ICSD and DSM definitions that not much has changed 
concerning the disorder’s clinical features. 
Onset of narcolepsy is most likely to occur in the mid 20’s with approximately 50% of 
the known cases being preceded by an abrupt change in the sleep pattern or a severe 
psychological stressor (Guilleminault & Anagnos, 2000). The prevalence of narcolepsy has been 
estimated at .02-.06% (Hublin, Partinen, Kaprio, Koskenvuo, & Guilleminault, 1994; Mignot, 
1998). However, due to the genetic components of the disorder, prevalence rates may vary 
significantly by region. A large body of research has been conducted concerning the genetic 
transmission of narcolepsy. It is reasonable to conclude that there is a strong genetic basis to the 
disorder (Guilleminault & Anagnos, 2000). Juji, Satake, Honda, and Doi (1984) found that 85% 
of their sample of persons with definite cataplexy shared a common human leukocyte antigen 
(HLA) allele on chromosome 6. However, Guilleminault, Mignot, and Grumet (1989) showed 
that this same genetic marker is also found in 12-38% of the general population. Thus, it is likely 
that the development of narcolepsy is the possible result of a specific genetic vulnerability 
combining with environmental and psychological stressors.
A large portion of the process of diagnosing sleep disorders consists of ruling out other 
causes. Because of the similarity of presentation of symptoms among these disorders, this 
process may be quite lengthy. Disorders of hypersomnia such as idiopathic hypersomnia or 
narcolepsy may impair a number of areas related to daytime functioning and sleep. However, as 
with insomnia, these symptoms are not exclusively due to hypersomnia but may be caused by 
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other disorders of sleep such as sleep apnea. When evaluating for possible causes of 
hypersomnia, breathing related sleep disorder (BRSD) should also be considered.
Breathing-Related Sleep Disorder
BRSD can consist of apneas (breathing cessation), hypopneas (slow or shallow 
breathing), and hypoventilation (low oxygen blood levels). Three forms of BRSD are recognized 
in the DSM-IV-TR: obstructive, central, and central alveolar hypoventilation. In obstructive 
sleep disorder the central nervous systems regulation of sleep breathing is maintained although 
breathing is inhibited, usually due to some physical obstruction of the upper airway (Ayappa & 
Rapoport, 2003). This form of BRSD is the most common and occurs more frequently in 
overweight individuals. Characteristics of obstructive sleep disorder include loud snores and 
brief gasps with alternating silence. Snoring can be quite loud and can significantly disrupt the 
sleep of bed partners or other persons living in the home. 
Central BRSD consists of cessation of sleep breathing without obstruction of breathing 
passages. Central BRSD is usually the result of a cardiac or neurological condition. Because of 
its presentation, central BRSD is much less noticeable than obstructive BRSD. In alveolar 
hypoventilation, low blood oxygen levels and high carbon dioxide levels are present in spite of 
normal lung mechanics. Shallow or slow breathing may be the cause. As with obstructive sleep 
apnea, obesity is a prime cause.
There are a number of recognized risk factors for developing BRSD, the most frequently 
noted include high body mass, craniofacial malformations, and male gender (Jordan & McEvoy, 
2003; Redline & Tishler, 2000). The discrepancy in prevalence between males and females may 
be due in part to the differing distribution of fat throughout the body between males and females. 
In a study evaluating gender differences in sleep disordered breathing, Young (1993) found that 
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gender differences were eliminated when waist-hip ratio and neck girth were analyzed instead of 
their body mass index (BMI). However, there is some evidence that female sex hormones may 
serve a protective role against developing BRSD (Jordan & McEvoy, 2003). Likewise, women 
appear to have shorter soft-palates, which reduces the potential for collapse of the upper airway 
during sleep, causing obstruction (Jordan & McEvoy, 2003).
The value of clinical impressions in the diagnosis of BRSD is questionable, showing poor 
sensitivity and specificity (Hoffstein & Szalai, 1993; Viner, Szalai, & Hoffstein, 1991). 
Considering the high correlation of BRSD with various physical features of the individual, 
Kushida, Efron, and Guilleminault (1997) developed a predictive model of obstructive sleep 
apnea. Their model, which is based upon BMI, neck circumference, and various craniofacial 
measurements, was used to correctly classify 98% of individuals with obstructive sleep apnea. 
While their model is an improvement over simple clinical impressions or history taking, PSG 
remains the most common method of assessment of BRSD and is considered the gold standard 
(Chervin, 2000). Because of the cost and intrusiveness of PSG in laboratory settings, efforts have 
been made to develop portable recording devices. However, not much data have been collected 
concerning the reliability of these devices in regards to laboratory PSG (Chervin, 2000).
Circadian Rhythm Sleep Disorder
The synchronization of internal processes such as sleep-wake cycles with the external 
environment depends upon how well the circadian clock is in tune with the world around us 
(Baker & Zee, 2000). A number of naturally occurring cues are used to reset or realign the 
timing of our internal clock with the external environment. These cues are known as zeitgeibers, 
or “time-givers”. Of the known zeitgebers, light has the strongest effect (Avissar, et al., 1999; 
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Wirz-Justice, 1998). Many other zeitgebers have been identified such as food consumption, 
temperature, social cues, and physical activity. 
By a series of ablation studies in rats, Richter (1967) found that only lesions of the 
hypothalamus resulted in a loss of circadian rhythm. Because of the known role that light plays 
in regulating circadian rhythms, it was hypothesized that by tracing projections from the optic 
nerve, the specific area concerned with regulating circadian rhythms could be identified (Moore 
& Eichler, 1972). Indeed, such a projection was found to lead to the suprachiasmatic nucleus 
(SCN; Moore & Eichler, 1972). Various ablation studies have confirmed the SCN’s role in 
synchronizing sleep with the external environment (Moore & Lenn, 1972; Stephen & Zucker, 
1972). However, the specific mechanism by which it does so remains unknown (Harrington & 
Mistlberger, 2000). Further, a number of other regions such as the pineal gland have been 
implicated in the process of circadian regulation.
A malleable system of sleep regulation is needed due to naturally occurring variations in 
the environment such as seasonal changes. Unnatural variations such as late-shift work and 
traveling through time zones also requires a system that is malleable and able to be reset. 
However, these unnatural variations may be too severe and sleep problems may arise when the 
synchronization of internal cycles with external cycles is lost. Desynchronization, or phase shifts, 
may occur for multiple reasons, which are commonly classified into two categories: (1) the 
environmental light/dark cycles changes relative to the individual’s internal clock (shift work or 
time-zone travel) or (2) the individual’s internal clock changes relative to stable environmental 
cycles (Baker & Zee, 2000).
The essential problem with circadian rhythm sleep disorder is that the individual is 
unable to sleep when it is desired or socially expected. In circadian rhythm sleep disorder, the 
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actual process of sleep remains unimpaired, however, the timing of sleep is mismatched with the 
environment. As with many sleep disorders, the presenting complaint is often insomnia or 
excessive daytime drowsiness. However, in circadian rhythm sleep disorder further investigation 
will show that the problem is not necessarily with falling asleep, but rather the timing of sleep 
onset. As with most sleep disorders, PSG is the gold standard for the diagnosis. Actigraphy and 
self-report of problems are also helpful in determining the specific characteristics of the disorder.
Parasomnias
Non-REM Parasomnias
Sleep-walking, sleep terrors, and confusional arousal are typically grouped together 
because they almost exclusively occur during NREM sleep, have similar genetic patterns, and 
are more common in children (Broughton, 2000). Indeed, the ICSD recognizes this grouping as a 
category, however the DSM-IV-TR does not categorize them but simply lists each as an 
individual parasomnia. These disorders also occasionally overlap with one another with aspects 
of confusional arousal being present in both sleep terrors and sleep-walking (Broughton, 2000).
As may be implied by its title, confusional arousal consists of periods of confusion after 
arousal from sleep, most commonly during slow wave sleep. While the ICSD recognizes this 
particular disorder, the DSM-IV-TR does not provide a specific diagnostic code. Little has been 
done concerning epidemiological studies of confusional arousal. Likewise, little is known 
concerning the pathophysiology. However, factors that may deepen sleep such as youth, 
medication, or sleep deprivation may increase the frequency of occurrence (Broughton, 2000). 
Confusional arousal usually does not impair the individual as long as objects are not left near the 
bed such as water glasses that may be broken and cause injury. 
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Sleep terrors consist of abrupt awakenings from sleep with loud screams or crying as well 
as autonomic arousal and feelings of intense fear. Both the ICSD and DSM-IV-TR recognize 
sleep terrors as a disorder. Sleep terrors occur primarily in children, with one to six percent 
experiencing the disorder (Broughton, 2000; Kales, Kales, Soldatos, Caldwell, Charney, & 
Martin, 1980). The condition is found far less frequently in adults with less than one percent 
experiencing the disorder. There appears to be a strong genetic component to sleep terrors 
(Kales, Soldatos, Bixler, Ladda, Charney, Weber, & Schweitzer, 1980). However, the 
pathophysiology remains unknown (Broughton, 2000). As with confusional arousal, while 
unpleasant and distressing, sleep terrors rarely cause injury nor serve as signs of other more 
serious disorders.
According to the ICSD, sleep-walking consists of the individual arising from a deep 
sleep, usually slow wave sleep, and engaging in a series of complex behaviors, resulting in 
getting out of bed and walking. In spite of previously held notions that sleepwalking was a 
significant sign of other pathology, it usually causes minimal harm and will resolve itself if 
allowed to “run itself out” (Broughton, 2000). Sleepwalking is common in children with three to 
four percent having frequent sleepwalking episodes (Kales, Soldatos, Caldwell, Kales, 
Humphrey, Charney, & Schweitzer, 1980). As with sleep terrors, there appears to be a genetic 
component, with roughly 80% of sleepwalkers having a significant family history (Kales, 
Soldatos, Caldwell, et al, 1980).
REM Parasomnias
REM sleep behavior disorder (RBD) and nightmares are the two most commonly 
researched REM sleep disorders. Nightmares are a common occurrence for most individuals and 
lifetime prevalence may be assumed to approach 100% (Nielsen & Zadra, 2000). While some 
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debate continues over what constitutes a nightmare, it is commonly held that nightmares are 
frightening dreams that awaken the individual. Nightmares are more common in children and 
decrease with age. However, it is not uncommon for nightmares to occur in adulthood, with 
estimates ranging from 8-25% (Nielsen & Zadra, 2000).
REM sleep behavior disorder (RBD) consists of the loss of atonia associated with REM 
sleep and excessive motor movements related to dream content. In RBD, injury may occur to the 
individual or bed partner as often the movements reflect punching or kicking motions. The atonia 
seen during REM sleep is primarily the result of inhibition of motor activity by the pontine 
centers of the peri-locus ceruleus, which in turn causes the medulla to hyperpolarize the motor 
neurons of the reticulospinal tract (Mahowald & Schenck, 2000). As the central nervous system 
develops during infancy, the REM atonia becomes more stable and movement during REM sleep 
decreases. Any impairment in the structures regulating the inhibition of motor activity may result 
in RBD. Chronic cases are usually related to neuromaldevelopment or neurological damage. 
Acute problems of RBD have been observed in persons taking excessive amounts of caffeine, 
tricyclic antidepressants, monoamine oxidase inhibitors, and various antipsychotics (Mahowald 
& Schenck, 2000). Because of the association with Parkinson’s disease and dementia, 
individuals with chronic cases should be evaluated by a neurologist to rule out these disorders.
Sleep Bruxism
Sleep Bruxism (SB) is defined by the ICSD as a stereotyped movement disorder 
characterized by grinding or clenching of the teeth during sleep. The disorder is differentiated 
from daytime clenching and grinding of teeth in that it takes place while sleeping and thus is 
believed to not be under volitional control. There is evidence to suggest a psychological 
component in that SB increases following stressful days or in anticipation of stress (Funch & 
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Gale,1980; Rugh & Solberg, 1975). SB can lead to severe wearing away of the teeth as well as 
damage to the bone and muscles of the jaw. This problem may result in significant tooth and jaw 
pain, as well as temporal area headaches. SB does not usually occur every time the individual 
sleeps but rather has a good deal of fluctuation (Lavigne & Manzini, 2000). SB is usually not 
noticed unless the individual’s bed partner is disturbed by the grinding noises or the individual’s 
dentist observes the tooth wear (Lavigne & Manzini, 2000). While SB is usually the primary 
diagnosis, it may occur secondary to a medical condition. For example, withdrawal from 
neuroleptics or neuroleptic induced dyskinisia may cause non-volitional jaw movements that 
persist during sleep. In such a case, the SB would be secondary to the dyskinisia (Micheli, 
Pardal, Gatto, Asconapé, Giannaula, & Parera, 1993; Bassett, Remick, Blasberg, 1986). Due to 
the inherent difficulty in observing SB and the individual’s frequent lack of awareness of the 
occurrence of SB, prevalence estimates are preliminary. Estimates of frequent SB in the general 
population range from 5-20% (Glaros & Rao, 1977). However, infrequent teeth grinding during 
sleep is fairly common, occurring in 85-90% of the population (Bader & Lavigne, 2000). It is 
only when the SB causes severe tooth wear or disturbs the sleep of the individual or their bed 
partner that it becomes clinically significant.
The etiology of sleep problems is diverse. Many disorders of sleep may result in similar 
symptoms. Various mental disorders or medical conditions may also lead to sleep problems. 
Because these various factors work in concert with one another, a thorough evaluation must also 
consider the role that mental disorders or medical conditions may play in sleep disturbances.
Mental Disorder or Medical Condition
Sleep disorders due to another mental disorder or medical condition are often not 
diagnosed or are simply overlooked. The diagnosis of these sleep disorders is often difficult due 
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to the inclusion of sleep disturbance as a criteria for other mental disorders such as Major 
Depressive Disorder or Generalized Anxiety Disorder. However, even when due to another 
disorder, the sleep disturbance may become of such a magnitude that it takes on a life of its own 
and warrants a second diagnosis. For the diagnosis of sleep disorders related to another mental 
disorder or medical condition, the ICSD provides much more definitive categories than the 
DSM-IV-TR, which simply calls for the clinician to specify which disorder is the primary cause 
of the sleep disturbance. The ICSD list of mental disorders includes psychosis, mood disorders, 
anxiety disorders, panic disorders, and alcoholism. The ICSD list of neurologic disorders 
includes cerebral degenerative disorder, dementia, parkinsonism, fatal familial insomnia, sleep-
related epilepsy, electrical status epilepticus of sleep, and sleep-related headaches. The list of 
other medical disorders includes: sleeping sickness, nocturnal cardiac ischemia, chronic 
obstructive pulmonary disease, sleep-related asthma, sleep-related gastroesophageal reflux, 
peptic ulcer disease, and fibromyalgia. With its specific categories, the ICSD system is more 
readily adapted to compiling epidemiological and statistical information.
As can be seen from the long list of mental and medical disorders that the ICSD includes, 
sleep disturbances may arise from disparate sources. No one particular health professional will 
receive all referrals that may be related to a sleep disorder. Physicians, psychologists, 
psychiatrists, neurologists, and nurses all need to be aware of the impact that sleep problems may 
have on the disorders that define their specialty. A brief review will be provided of those 
disorders that are the most commonly reported in persons with intellectual disabilities. These 
conditions include depression, anxiety, and epilepsy.
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Anxiety and Depression
When discussing sleep disorders in the context of anxiety and depression, much of the 
research becomes blurred. This problem is due in part to the overlap of disorders and sleep 
problems that are often conceptualized as symptoms of depression and anxiety (Ware & Morin, 
1997). Further, considering the high prevalence of anxiety and mood disorders across the 
lifespan, little research has been done concerning their impact on sleep or vice-versa (Uhde, 
2000). Nonetheless, the available research does indicate a significant relationship between sleep 
and these disorders (Benca, 2000; Uhde, 2000).
Relaxing before bedtime is a significant step in settling before sleep onset. However, 
many individuals with anxiety disorders report worrying and thinking about problems after 
laying down to sleep (Uhde, 2000). This situation may pose a significant problem to the process 
of winding-down (Spielman, Conroy, & Glovinsky, 2003). Indeed, 50% to 70% of persons with 
generalized anxiety disorder report problems with sleep and 30% report moderate to severe 
problems (Anderson, Noyes, & Crowe, 1984; Uhde, Tancer, & Gurguis, 1990). Additionally, 
intrusive thoughts and ruminations have been shown to disrupt sleep in person with obsessive 
compulsive disorder, with these individuals showing fragmented and restless sleep (Insel, Gillin, 
Moore, Mendelson, Loewenstein, & Murphy, 1982; Uhde, 2000). Post-traumatic stress disorder 
(PTSD) poses a particular problem to sleep, particularly in having trouble initiating sleep or with 
recurrent nightmares. Further, the individual with PTSD may develop a conditioned fear to sleep 
if the trauma occurred while they were sleeping, such as a house-fire or burglary (Uhde, 2000). 
Since sleep problems are a diagnostic criteria for mood disorders, the high association of 
insomnia and depression should not be surprising. Mellinger, Balter, and Uhlenhuth (1985) 
found that persons with serious insomnia complaints were much more likely (three times more 
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likely) to report depression than those with only minor complaints of insomnia. While 
conventional wisdom holds that depression causes impairment in sleeping, there is increasing 
evidence that impaired sleep may also cause depression. For example, Ford and Kamerow (1989) 
found that individuals whose sleep disturbances persisted between baseline assessment and a 1-
year follow-up were much more likely to have developed a new major depressive disorder. A 
similar study (Breslau et al.,1996), which did not include sleep disturbances as a criteria for 
depression, also found that sleep disturbances were a significant risk for developing a depressive 
disorder. Similarly, treating sleep disturbances have been shown to be effective in reducing 
anxiety and depression (Jacobs et al., 1993)
A number of theories have been proposed to account for the role that sleep plays in 
anxiety and depression. These theories consider REM suppression, cholinergic-aminergic 
imbalance in REM sleep regulation and problems with the circadian regulation of sleep/wake 
cycles. While no one theory is able to explain the various symptoms, sleep and anxiety and sleep 
and depression appear to be significantly linked (Benca, 2000). Examining these links may lead 
to more effective treatments for sleep disorders as well as for depressive and anxiety disorders.
Epilepsy
Many individuals who experience nocturnal seizures are not aware of the seizure activity 
at all, but rather present with complaints of sleep fragmentation, poor sleep quality, and daytime
tiredness (Provini, Plazzi, Montagna, & Lugaresi, 2000). Many nocturnal seizure disorders will 
remit without treatment; this is particularly the case in children (Pressman, Gollomp, Benz, & 
Peterson, 1997). Seizure activity and sleep disorders appear to be significantly related to one 
another. Sleep deprivation has been shown to increase seizure activity (Shouse & Mahowald, 
2000). However, seizures may also increase the incidence of sleep disorders. To further 
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complicate the picture, anticonvulsants have a significant impact on REM sleep, and epileptic 
discharges have been known to exacerbate periodic limb movements (Pressman et al., 1997). 
Some parasomnias such as arousal disorders are often misdiagnosed as nocturnal 
seizures. Indeed, there is a good deal of overlap between sleep and epileptic phenomena 
(Eisenman, & Attarian, 2003). For example, normal occurrences in sleep such as hypnic jerks, 
which involve motor, visual, auditory, or somethetic sleep starts may be confused as seizure 
activity (Shouse & Mahowald, 2000). However, these events may also be the only manifestation 
of a seizure disorder (Fornazzari, Farcnik, Smith, Heasman, & Ichise, 1992). Additionally, 
disorders of arousal such as REM sleep behavior disorder, nightmares, periodic limb movement
disorder, nocturnal panic attacks, and enuresis may have significant overlap with seizure 
disorders. Differential diagnosis is extremely difficult. Standard practices to assess for seizures 
such as EEG recordings may be obscured by normal sleep phenomena. In light of the 
complicated diagnostic picture and the common comorbidity of sleep and seizure disorders, an 
awareness of both sleep and seizure disorder manifestations is necessary (Shouse & Mahowald, 
2000). The clinician needs to be vigilant in exploring both possibilities, especially in such cases 
where the phenomena may lead to injury.
Sleep Disorders in Persons with Intellectual Disabilities
Prevalence and Classification Issues
The prevalence of sleep problems in persons with intellectual disabilities appears to be 
much higher than in the general population (Brylewski  & Wiggs, 1998; Brylewski & Wiggs, 
1999; Stores, Stores, & Buckley, 1996; Wiggs & Stores, 1996). For example, Bartlett, Roney, 
and Spedding (1985) conducted a study in which 80% of the parents of children with intellectual 
disabilities reported one or more difficulties related to sleep. Didden et al. (2002) reported 
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settling, night waking, and early waking as the most common of the severe problems reported in 
children with intellectual disabilities. Quine (1991) also reported a high prevalence of sleep 
problems with 51% of the sample having settling problems and 67% having problems with 
waking during the night. Further, Stores et al. (1996) found that children with intellectual 
disabilities were much more likely to have a sleep problem than typically developing children. 
Thus, it is apparent that persons with intellectual disabilities appear to be particularly vulnerable 
to sleep problems. 
Most studies published concerning sleep problems in persons with intellectual disabilities 
have been with children (Didden & Sigafoos, 2001; Espie & Tweedie, 1991). Quine (1991) and 
Clements, Wing, and Dunn (1986) both found sleep disorders to be more common in children 
under 5 than children over 5. The period of sleep problems experienced in the early development 
of typically developing infants might apply to persons with intellectual disabilities. Indeed, 
Bartlett et al. (1985) indicated that those children with intellectual disabilities in their study 
appeared to be significantly slower at “growing-out” of sleep problems than were typically 
developing children. Few studies have been published concerning the prevalence of sleep 
problems in adults with intellectual disabilities. Brylewski and Wiggs (1999) evaluated 205 
adults with intellectual disabilities for sleep problems. They reported the most frequent sleep 
problem to be night waking, which occurred in approximately half of their sample. 
A number of individuals with intellectual disabilities suffer from brain damage or 
neuromaldevelopment. Neurological impairments such as severe locomotor disability, blindness, 
and epilepsy were found to be predictors of sleep problems in persons with mental retardation 
(Lindblom, Heiskala, Kaski, Leinonen, Nevanlinna, Iivanainen, & Laakso, 2001). Further, 
damage to the structures that regulate REM sleep (pontine and forebrain), circadian rhythms 
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(suprachiasmatic nucleus), and activation and arousal (ascending reticular formation) will likely 
lead to disorders of these sleep systems. Indeed, REM sleep phase is one area in which 
abnormalities may be found between persons with intellectual disabilities and the general 
population (Grubar, 1983).
Breathing problems are an area that is of particular risk for persons with intellectual 
disabilities. Problems related to breathing may result from any physical abnormality that 
compromises an individual’s ability to breathe easily such as craniofacial abnormalities, scoliosis 
of the spine, and disorder of the upper airway. Stores et al. (1996) found that children with 
Down’s syndrome were particularly vulnerable to breathing related sleep problems. These 
differences are most likely due to the physical differences found in Down’s syndrome, 
particularly concerning craniofacial development. 
In addition to physical abnormalities, the problem of discerning the etiology of sleep 
problems is further complicated by the prevalence of medication use in this population. Lipman 
(1970) found that psychotropic medications were taken by 51% of persons living in a residential 
facility. A high prevalence of psychotropic use among persons with intellectual disabilities not 
living in institutions has also been reported. Aman, Sarphare, and Burrow (1995) reported the 
prevalence of receiving psychotropic medications to be 27% among persons with intellectual 
disabilities living in community group homes. The most common psychotropics were 
neuroleptics and anticonvulsants. Common side effects included sedation, daytime fatigue, REM 
disturbance, and disturbed nocturnal sleep (Hoeppner, Garron, & Cartwright, 1984; Wetter, 
Lauer, Gillich, & Pollmächer, 1996). Medication use may account for a number of the reports of 
sleep problems among these individuals. However, no systematic studies evaluating the role of 
psychotropic drug use on sleep problems in this population have been conducted. 
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Another factor that requires consideration is that a large number of individuals with 
intellectual disabilities suffer from seizure disorders. The abnormal brain activity associated with 
seizures has the potential to alter a number of sleep systems. However, Espie and Tweedie 
(1991) point out that this has been widely overlooked by researchers evaluating sleep disorders 
in persons with intellectual disabilities. The frequent misdiagnosis of parasomnias as seizures 
and vice-versa is further complicated in this population, who have a much higher incidence rate 
of both seizure and sleep disorders (Deb & Joyce, 1999; Shepard, & Hosking, 1989; Steffenburg, 
Hagberg, & Kylerman, 1996). The cyclical nature of sleep and seizure disorders only further 
serves to increase the risk for persons with intellectual disabilities to develop sleep problems.
Persons with intellectual disabilities are a population warranting significant inquiry 
concerning sleep problems. However, relative to the enormous body of research on sleep 
disorders in the general population, these problems in persons with intellectual disabilities have 
been overlooked. Of those studies that have been concerned with sleep problems in persons with 
intellectual disabilities, most only looked at sleep in children. Indeed, the only measure 
specifically designed to evaluate sleep problems in this population, the BEDS, is designed for 
use with children (Schreck, 1997/1998).
Treatment of Sleep Disorders in Intellectual disabilities
The treatment of sleep disorders is highly specific to the particular symptom 
manifestation. While there is a good deal of discussion concerning whether behavioral or 
pharmacological treatments should be used as first line treatments, a recent meta-analysis by 
Smith, Perlis, Park, Smith, Penington, Giles, and Buysse (2002) found both approaches to be 
equally efficacious. Identifying specific environmental and behavioral variables may lead to 
simple but effective treatments, without the risk of side-effects. However, Didden and Sigafoos 
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(2001) point out the general lack of well-controlled treatment studies in persons with intellectual 
disabilities. Nonetheless, there is a growing body of research available to suggest the efficacy of 
a number of treatments (Lancioni, O’Reilly, & Basili, 1999). 
Light therapy
Light therapy is a relatively easy and inexpensive method for treating sleep problems 
such as insomnia or circadian rhythm disorder. Light therapy may consist simply of exposure to 
bright natural or artificial light. Light therapy takes advantage of the strong role that light plays 
as a zeitgeiber. Exposure to bright lights is a well-established treatment in the general population. 
However, little has been done to explore the effectiveness of this treatment in persons with 
intellectual disabilities. The available evidence does indicate though that light therapy may be 
effective with this population. For example, Short and Carpenter (1998) report on the case of a 
34 year-old with profound mental retardation that had problems with fragmented sleep and 
daytime drowsiness. Following unsuccessful treatment attempts with sleep hygiene as well as 
hypnotic medication, a regimen of exposure to direct sunlight for 2 hours each morning was 
initiated. After two weeks of light therapy, his sleep stabilized and followed a normal pattern. 
More recently, Altabet, Neumann, and Watson-Johnston (2002) presented three case studies in 
which light therapy was effectively used to treat sleep problems. They also noted a decrease in 
irritability as measured by the Aberant Behavior Checklist (Aman & Singh, 1985) and 
depression as measured by the Diagnostic Assessment for Severe Handicaps (Matson, 1993). 
Light therapy is a promising intervention for treating various sleep problems in persons with 
intellectual disabilities. However, much still needs to be done to determine for which particular 
sleep problems it is effective. Likewise, more controlled studies are needed before one can 
accurately gauge its effectiveness.
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Chronotherapy
Chronotherapy was first developed as a treatment for delayed sleep phase syndrome. 
Basically, each day the individual’s bedtime is pushed back by one to two hours. This is 
continued until the appropriate bedtime is reach. In an evaluation of four congenitally blind 
children with circadian sleep-wake rhythm disorder, Okawa and colleagues (1987) found that 
chronotherapy was effective at entraining only one of the four children’s sleep cycles, with two 
of the children’s sleep cycles responding to hypnotic medications following the failure of 
chronotherapy. However, there is evidence showing improvement in sleep problems in persons 
with intellectual disabilities when treated with chronotherapy. For example, Piazza, Hagopian, 
Hughes, and Fisher (1998) report on the use of chronotherapy to effectively reduce sleep 
problems in an 8 year-old girl with autism. Chronotherapy was originally designed based upon 
the belief that the endogenous sleep-wake cycle in humans followed a 25-hour clock and that it 
would be the easiest approach to resetting the person’s sleep time to the desired schedule. 
However, later research has shown that the internal clock actually follows a cycle just over 24 
hours (24.18), reducing the overall rationale for pushing the bedtimes later rather than earlier 
(Stepanski & Perlis, 2003). Chronotherapy may be effective in some cases; however, considering 
the overall efficacy of this approach, other less disruptive methods such as light therapy may be 
preferred.
Sleep Hygiene
Sleep hygiene consists of day-to-day habits that either improve or degrade the quality and 
amount of sleep for an individual. Many different sleep hygiene lists have been constructed for 
research or clinical purposes, however, sleep hygiene lists do not vary dramatically and usually 
consist of the same core items. These items include: getting up at the same time each day, 
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keeping your bedroom free from light and noise, avoiding caffeine during the day and 
particularly in the evening, and avoiding long daytime naps. Good sleep hygiene practices may 
be of particular concern for persons living in residential care facilities, who often do not have 
much influence over their daily routines or sleeping environments. Likewise, daytime napping is 
often a frequent problem. While studies evaluating the use of sleep hygiene in persons with 
intellectual disabilities as the sole treatment are virtually nonexistent, it has been used as a 
component in a few studies. For example, Espie and Wilson (1993) report on the use of “optimal 
scheduling” to improve sleep problems in 5 persons with intellectual disabilities. This procedure 
was found to improve the overall sleep of the individuals in their study. However, results of their 
study are limited by an AB design. In another study, Gunning and Espie (2003) found that by 
using a combination of treatment components, which were individually tailored for each of their 
12 participants, sleep problems were effectively treated. The treatment components used in their 
study included optimal scheduling, sleep hygiene, stimulus control, relaxation, light therapy, and 
cognitive behavioral therapy.
Sleep hygiene is a basic treatment for good sleep habits. It is usually considered an 
adjunctive treatment though, requiring other more effective techniques to treat most sleep 
problems (Smith, et al., 2003). Nonetheless, it is a necessary consideration when dealing with 
persons with intellectual disabilities, who often do not have much personal control over these 
decisions. By caretakers making sleep hygiene a factor when determining schedule and 
environmental changes, the overall sleep quality for many of the individuals in their care may 
improve.
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Faded Bedtime
Faded bedtime procedures have been found to be an effective intervention for bedtime 
resistance and frequent night waking in children (Kuhn & Elliott, 2003). Fading usually consists 
of altering the bedtime daily by 30 minutes based upon the child being able to fall asleep within 
15 minutes. If the child does not fall asleep within 15 minutes, they are removed from bed and 
kept awake for a period of an hour. This procedure has been found to be relatively effective in 
reducing bedtime resistance and frequent night waking in persons with intellectual disabilities. 
For instance, Piazza and Fisher (1991) evaluated the use of bedtime fading and response cost for 
reducing sleep problems in 4 children with intellectual disabilities. Using a multiple-baseline 
across-subjects design, they found that sleep disturbances were significantly reduced as well as 
levels of appropriate sleep being improved. More recently, Piazza, Fisher and Sherer (1997) 
compared the efficacy of faded bedtime with response cost to bedtime scheduling. They found 
that sleep improved significantly more for the children in the faded bedtime with response cost 
group than in the bedtime scheduling group. 
Functional Analysis
Functional analysis is a useful tool to determine the environmental contingencies that 
cause and maintain behavior. The functional analysis approach is dependent upon the assumption 
that behavior is learned and maintained by environmental conditions. Much research has been 
done that validates this assumption (Bachman, 1972; Carr, 1977; Iwata, Dorsey, Slifer, Bauman 
& Richman, 1994), indicating that even maladaptive behaviors, such as self-injurious behavior 
(SIB) may also be learned. While it is less likely that some sleep disorders such as BRSD are 
operantly controlled, other sleep problems such as frequent night wakenings and disturbances are 
readily affected by behavioral reinforcement (Didden, Curfs, van Driel, & de Moor, 2002).
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There is increasing evidence for the use of functional assessment in the treatment of sleep 
problems in persons with intellectual disabilities. For example, Didden, Curfs, Sikkema, and de 
Moor (1998) conducted functional assessments for 6 boys with intellectual disabilities. Results 
of the functional analyses found that parent or caretaker attention maintained nighttime 
disruptions for 4 of the boys, anxiety for 1 of the boys, and a combination of seizure activity and 
attention for 1 boy. Extinction procedures were found effective at reducing nighttime disruptions 
maintained by attention. For the child in whom nighttime disruptions were maintained by 
anxiety, systematic desensitization was found effective. In a similar study, Didden et al. (2002) 
conducted individual functional analyses for 3 children and 1 adult with intellectual disabilities 
who were experiencing sleep problems. Using a multiple-baseline design, they found nighttime 
disruptions that were maintained by attention to be successfully reduced by extinction. Further, 
in a multiple-baseline design across subjects, Durand, Gernert-Dott, and Mapstone (1996) found 
that a combination of graduated extinction and consistent bedtime routines were successful at 
reducing nighttime wakenings and disturbances. 
Considering the functional variables that may maintain sleep problems is a useful step in 
devising effective treatments for sleep problems in persons with intellectual disabilities (Didden 
et al., 2002). However, most studies found nighttime disruptions to be maintained by social 
attention. While it is improbable that social attention maintains all occurrences of nighttime 
disruptions, studies evaluating the prevalence of the various maintaining variables may be able to 
identify particular variables that occur frequently, thus streamlining the assessment and treatment 
process. 
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Pharmacological Treatments
Pharmacological interventions are designed to primarily address one of two problems, 
excessive daytime sleepiness or insomnia. First line treatment for excessive daytime sleepiness is 
to target the underlying cause, which should be determined by a thorough evaluation. However, 
when treatment of the underlying cause is unsuccessful or not possible, psychostimulants may be 
a viable option. Psychostimulants that act on the sympathetic nervous system are termed 
sympatheomimetic, and include amphetamine derivatives such as dexamphetamine and 
methylphenidate. Historically the only non-sympatheomimetic psychostimulant popularly used 
was caffeine, however, a relatively new psychostimulant, modafinil, falls into this class. 
Methylphenidate is the most commonly prescribed psychostimulant (Challman & Lipsky, 2000), 
however, it is likely that a large portion of prescriptions for methylphenidate are not to treat 
daytime sleep disorders but other disorders such as Attention Deficit Hyperactivity Disorder. 
While the specific mechanism of action for modafinil are unclear, it has a benign side effect 
profile when compared to dexamphetamine and methylphenidate, which have a high abuse 
potential (Jasinski, 2000). Recently, modafinil has received a considerable amount of attention 
from researchers and is rapidly becoming the drug treatment of choice for excessive daytime 
sleepiness (Banerjee, Vitiello, & Grunstein, 2004). However, no controlled studies of modafinil 
in persons with intellectual disabilities have been conducted. 
Most pharmacological treatments for sleep disorders have addressed insomnia. While 
new agents are under development, all currently approved hypnotics act on the gama-
aminobutyric acid (GABA)- benzodiazepine receptor complex and are still considered the drug 
class of choice to treat insomnia (National Institute of Mental Health, 1984). In a survey of 
psychiatrists and internist, Silberman (1998) found a generally negative view of using 
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benziodiazepines for sleep problems. Likewise, prescription hypnotic use appears to be 
decreasing (Mendelson, et al., 2004). In a 20-year review, Balter and Uhlenhuth (1991) report a 
drop from 3.5 to 2.5% in persons who had been prescribed a hypnotic sleep agent. Further 
evidence of the decline in hypnotic prescriptions can been seen in the 10-year review by 
Schweitzer and Walsh (1998), who found a 20% decline in the use of hypnotic agents to treat 
sleep problems. 
While the use of hypnotic agents may be decreasing, there has been a dramatic increase 
in off-label use of antidepressants and anxiolytics (Mendelson et al., 2004). Further, the 
frequency with which over the counter medications are used to treat sleep problems should not 
be underestimated. Johnson, Roehrs, Roth, and Breslau (1998) found that alcohol and over the 
counter sleep aids were the most common methods used to treat sleep problems. Antihistamines 
and alcohol are readily available for most adults and do not require the time or expense of a 
doctor’s visit, which may account for their frequency of use over other sleep inducing agents. 
Few researchers have examined the use of pharmacological treatments for sleep problems 
in persons with intellectual disabilities. Despite the widespread use of these agents in persons 
with intellectual disabilities and the high prevalence of sleep problems in this population, little 
has been done to generalize the results found in general population studies to an understanding of 
the effectiveness of pharmacological treatments for persons with intellectual disabilities. What 
research exists appears to pertain almost exclusively to melatonin.
Melatonin is a well-established treatment for sleep problems in the general population 
that has received increasing attention for use in persons with intellectual disabilities. Melatonin 
administration has the opposite effect of exposure to bright light in that it advances the onset of 
sleep when taken in the evening whereas light exposure pushes sleep onset back (Lack & 
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Bootzin, 2003). There is some evidence suggesting the efficacy of melatonin administration in 
persons with intellectual disabilities. Jan, Espezel, and Appleton (1993) reported on 15 case 
studies in which melatonin treatment was found to significantly improve sleep. Likewise, Palm, 
Blennow, and Wetterberg (1997) found that melatonin treatment was effective for treating 
disturbed circadian sleep-wake rhythms in eight children. However, similar results have not been 
found in more rigorous experimental designs. For instance, in a series of 6 double-blind single-
subject experiments, Camfield, Gordon, Dooley, and Camfield (1996) report a general lack of 
response to melatonin. While some benefit was found as far as increasing overall sleep, the 
amount of increase was not clinically significant enough for the families of the participants to 
consider the long-term use of melatonin (Camfield et al., 1996). There is substantial evidence 
from studies of melatonin administration in the general population to expect melatonin 
administration to be effective in persons with intellectual disabilities. However, in light of the 
finding by Camfied et al. (1996), it is clear that more rigorous experimental studies are needed.
Considering the overall effectiveness of pharmacological interventions to treat sleep 
problems in the general population, it is unfortunate that so little has been done to evaluate its 
use in persons with intellectual disabilities. This is particularly striking in light of the 
comparatively high use of psychotropic medications in this population. One cannot simply 
assume that these interventions will have the same effects in persons with intellectual disabilities 
as has been found in the general population. More experimentally sound studies focusing on the 
use of these treatments in persons with intellectual disabilities are needed.
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RATIONALE
Sleep, a process often taken for granted, can disrupt many different areas of a person’s 
day-to-day living if significant problems develop (Breslau et al., 1996; Ford & Kamerow, 1989). 
Persons with intellectual disabilities frequently have a number of additional medical and 
psychological conditions, occurring at a much greater rate than in the general population. Indeed 
as discussed here, sleep disorders appear to occur at a much higher rate than in the general 
population based on available evidence (Stores et al., 1996). However, since most of these 
studies did not use measures designed for persons with intellectual disabilities, solid conclusions 
are tentative despite the serious potential for poor quality of life for these persons. Indeed, using 
scales that have been designed for use in the general population has multiple limitations when 
applied to persons with intellectual disabilities (Favell, Realon, & Sutton, 1996; Green, Gardner, 
& Reid, 1997). First, the format of most of these measures does not fit well. Almost all of the 
questionnaires that have been designed to assess sleep disorders in the general population rely on 
self-report. Many persons with intellectual disabilities are nonverbal and unable to report on 
issues such as sleep quality or duration, and even for those persons with some verbal skills, the 
likelihood of being able to comprehend the questions is highly unlikely. These issues are 
particularly true for those in the severe and profound range of mental retardation. Further, of 
those who are verbal, their verbal skills are usually poor and thus render any assessment based 
solely on self-report as incomplete and in need of supplemental sources of information. 
In response to these limitations, the SLEEPY was designed to be administered in an 
indirect format, thus allowing the clinician to inquire about an individual’s sleep behavior 
without the constraints of the individual’s ability to self-report. Further, the items on the 
SLEEPY were developed after an extensive review of reported sleep problems in persons with 
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developmental disabilities. Thus, the content of the SLEEPY is designed to specifically target 
sleep problems as they appear in persons with developmental disabilities. While the BEDS 
(Schreck, 1997) and the DASH-II (Matson, 1993) have been developed to assess for sleep 
problems in this population, the BEDS was designed for the assessment of sleep problems in 
children. Little is known concerning the developmental course of sleep problems across the 
lifespan for individuals with developmental disabilities. It is likely that the type of sleep 
problems will differ as the individual ages, as is seen in the general population. The DASH-II has 
been developed to screen for psychopathology in adults. However, as is the nature of screening 
instruments, the content is limited and designed to alert care-providers to areas that require 
further inquiry. The SLEEPY was designed to serve as a systematic method to be used as that 
second line of inquiry or as a stand-alone assessment for possible sleep problems. 
Nonetheless, for such a scale to have utility, its reliability and validity need to be 
established. The present study reports on the development of the SLEEPY and serves as an initial 
effort to evaluate its reliability and validity. In particular, an item analysis was conducted to 
remove any items with poor reliability or low endorsement. Secondly, the factor structure of the 
remaining items was evaluated to develop subscales of the SLEEPY. Further, the test-retest and 
inter-informant reliability of the subscales were evaluated. Finally, the validity of the SLEEPY 
was evaluated in two ways. First, scores on the SLEEPY were compared to scores on the DASH-
II sleep subscale. Secondly, responses to SLEEPY items were compared to direct behavior 
observations for a 24-hour period. 
The development of a scale to reliably and validly assess sleep problems in this 
population is of considerable importance. Such a scale has the potential to do much to improve 
the quality of life for individuals with developmental disabilities who have suffered from sleep 
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problems that have gone unnoticed. Further, research in the epidemiology and treatment of sleep 
problems in persons with developmental disabilities has been hindered by the absence of 
systematic means of assessment.
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METHOD
Participants
All participants were recruited from Pinecrest Developmental Center (PDC) in Pineville, 
Louisiana. PDC is a residential developmental center that provides services for approximately 
580 individuals with intellectual disabilities. Residents at PDC present with a variety of physical 
and intellectual disabilities. Most of the individuals at PDC function in the range of severe and 
profound mental retardation. 
The SLEEp Problems InventorY (SLEEPY) is an indirect measure of sleep problems that 
is designed to be administered in an interview format with a staff member who is familiar with 
the day-to-day behavior of the individual. At PDC, each direct care staff member (group leader) 
provides services for three to four individuals. Thus, the same person may serve as an informant 
for up to four different individuals. Institutional Review Board approval for this project was 
obtained through a previous proposal entitled: “Norming Psychological Assessment Battery for 
Treatment Plans”.
A total of 400 participants were recruited. These individuals were randomly selected 
from the overall population of residents at PDC. The sample of 400 participants consisted of 216 
males and 184 females. Age ranged from 18 to 87 years (mean = 50.61 SD=13.36). Deafness 
was present in 25 individuals (6.3%), blindness in 54 (13.5%), seizure disorder in 149 (37%), 
226 were nonverbal (56.5%), and 136 were non-ambulatory (34%). The majority of the 
participants functioned within the range of profound mental retardation (75%). Table 1 displays 
the demographic information for the entire sample of 400 participants. 
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Table 1
Demographic Characteristics of Participants
Demographic Frequency Percent of Sample
Gender
Male 216 54
Female 184 46
Age
0-21 3 0.8
22-45 129 32.3
46-65 213 53.3
66+ 55 13.8
Level of Mental Retardation
Mild 5 1.3
Moderate 21 5.3
Severe 41 10.3
Profound 301 75.3
Unspecified 32 8
Inter-Informant Reliability
For a scale to have utility, staff and others familiar with the client must be able to 
generally agree on which sleep items do and do not occur. In an effort to assess for error variance 
due to differences among direct-care staff reports, 20% of the overall sample received 
independent administrations of the SLEEPY by the same interviewer with an additional staff 
member who had known the participant for at least 6 months and reported knowing well the 
daily behavior of the participant. Because the SLEEPY is scored on an interval scale, the most 
appropriate measure of inter-informant reliability is the Pearson product-moment correlation 
(Haynes & O’Brien, 2000). Correlations were computed between raters in regards to severity as 
well as for dichotomous scores (endorsement of the item occurring or not).
Participants were randomly selected from the overall participant pool of 400 individuals. 
The demographics from the inter-informant sample reflect those of the overall study sample. 
Demographic information for the inter-informant sample is shown in Table 2.
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Table 2
Demographic Characteristics of Participants in the Inter-Informant Sample
Demographic Frequency Percent of Sample
Gender
Male 44 54.3
Female 37 45.7
Age
0-21 1 1.2
22-45 22 27.2
46-65 44 54.3
66+ 14 17.3
Level of Mental Retardation
Mild 2 2.5
Moderate 2 2.5
Severe 7 8.6
Profound 66 81.5
Unspecified 4 4.9
Test-Retest Reliability
In order to assess for error variance due to time sampling, 20% of the overall sample of 
participants received a second administration by the same interviewer with the same informant 
following a 1-2 week interval. The error variance between administrations may be influenced by 
a number of factors including non-standardized administration, environmental changes, and 
changes in the informant such as mood or level of arousal (Anastasi & Urbina, 1997). Regardless 
of the source of variance, the more susceptible a measure is to changes in variables other than 
that of the target construct, the less useful that measure becomes. Test-retest reliability was 
computed between raters in regards to severity. The reliability coefficient is an index of 
agreement between subsequent administrations of a measure by the same person (Anastasi & 
Urbina, 1997). For the present study, the reliability coefficient was computed by the Pearson 
product-moment method.
Participants for the test-retest sample were randomly selected from the overall participant 
pool of 400 individuals. The demographics from the test-retest sample also reflect those of the 
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overall population. However, subjects selected for the test-retest sample had slightly more males 
than females, which is the opposite of the overall sample. Demographic information for the test-
retest sample is shown in Table 3.
Table 3 
Demographic Characteristics of Participants in the Test-Retest Sample
Demographic Frequency Percent of Sample
Gender
Male 35 43.8
Female 45 56.3
Age
0-21 0 0
22-45 24 30
46-65 40 50
66+ 16 20
Level of Mental Retardation
Mild 1 1.3
Moderate 7 8.8
Severe 9 11.3
Profound 57 71.3
Unspecified 6 7.5
Measures
Rating Scales
Over the past 10 years, rating scales have emerged as a viable means of assessing for 
disorders or measuring skills in persons with intellectual disabilities (Matson & Bamburg, 1998; 
Matson, LeBlanc, Weinheimer, & Cherry, 1999). Typically, they are administered in an 
interview format with a person who is familiar with the individual such as a direct-care staff 
member or a parent. Rating scales used in the present study included the SLEEPY and the 
DASH-II.
SLEEPY
The SLEEPY is a measure designed to assess for symptoms of sleep disorders in persons 
with developmental disabilities. The items on the SLEEPY were constructed by reviewing 
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reports of particular symptoms of sleep disorders in persons with developmental disabilities in 
published studies over the past 20 years. The SLEEPY was designed to be administered in an 
interview format to a person who is familiar with the day-to-day behavior of the individual being 
assessed. Items on the SLEEPY consist of statements about sleep-related behaviors of the 
individual (i.e. “Will fall asleep if not otherwise occupied”). Each item of the SLEEPY is rated 
on a three-point scale concerning the accuracy of the statement as well as the duration of the 
behavior. The SLEEPY consists of both the questionnaire and a score sheet.
The SLEEPY is designed to serve two purposes. First, to act as a screening device that 
alerts care providers to the possible presence of a sleep disorder, with the goal of leading to more 
accurate referrals for the less efficient but more definitive procedures such as polysomnography. 
The second goal of the SLEEPY is to provide areas for possible immediate intervention. 
Diagnostic Assessment for the Severely Handicapped-II (DASH-II)
The DASH-II is an 84-item, informant-based screening tool designed to provide 
information for the diagnosis of psychopathology for persons within the severe and profound 
range of mental retardation. The scale is comprised of subscales representing 13 diagnostic 
categories: (1) anxiety, (2) depression, (3) mania, (4) autism and other pervasive developmental 
disorders, (5) schizophrenia, (6) stereotypies and tics, (7) self-injurious behavior (8) elimination 
disorders, (9) eating disorders, (10) sleep disorders, (11) sexual disorders, (12) organic 
syndromes, and (13) impulse control and other miscellaneous behaviors. All items are rated on 
frequency, duration, and severity on a 0-2 Likert scale. 
Behavior Observations
Sleep data was collected using momentary time-sampling (MTS) with 30-minute 
intervals. Each participant was observed individually for a period of 2 minutes. The observations 
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continued for a 24-hour period, resulting in 48 observations per participant. During the 
observation period the observer recorded the behavior of the participant as well as various 
environmental variables. Operational definitions for the target behaviors consisted of 1) sleeping: 
defined as eyes closed, all movement or vocalizations appear sleep related; 2) snoring: defined as 
audible breathing difficulties causing harsh snorting noises; 3) out of bed: not in bed for any 
reason, regardless of sleep status; 4) in bathroom: defined as in bathroom regardless of activity or 
sleep status; and 5) bruxism: defined as audible grinding or clicking noises while sleeping. 
Environmental variables consisted of 1) temperature, as measure by a thermometer, 2) sound 
level, as measured by a decibel meter; and 3) level of light, defined as dark, no light; dim, partial 
light; or light, room lights on or in direct sunlight. These target behaviors and environmental 
variables were selected to correspond to various items on the SLEEPY. 
A second independent observer recorded data in order to compute the inter-informant 
reliability of the behavior observations. For the inter-informant reliability observations, both 
observers entered the room and observed the individual at the same time. Inter-informant 
reliability data were collected on 20% of the sleep log participants. While a second observer was 
available to collect reliability data for 100% of the sleep log sample, inter-informant 
observations were limited to 20% in an effort to reduce any disturbance that the observations 
may have caused to the participants. Agreement was defined as an interval in which both the 
primary and secondary observer recorded the same occurrence of a behavior. Agreement 
between observers were computed by dividing the number of agreements by the number of 
agreements plus disagreements, then multiplying by 100 (Alberto & Troutman, 2003). Due to 
unforeseen schedule changes among the participants in the sleep log sample, the two data 
collectors for the daytime period were required to both serve as primary observers at different 
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locations. Thus, calculations of the inter-informant reliability for the sleep log observations were 
only available for the nighttime observations. Inter-informant reliability for the nighttime 
observations was 100%.
Procedures
The SLEEPY was administered to direct-care staff by master’s-level clinicians. 
Informants were selected based upon extensive experience with the participant (i.e., each 
informant must have worked with the respective study participant for at least six months). In 
most circumstances, the person who was the most qualified to serve as an informant was the 
individual’s group leader. Further, the items on the SLEEPY are designed to measure sleep 
problems that may occur throughout the entire 24-hour period. Because of the different times in 
which sleep problems may occur, a single informant may not be able to report accurately 
concerning behaviors that primarily occur when they are not present. For this reason, the initial 
items on the SLEEPY were divided into two sections: Morning/Day and Evening/Night. 
Informants responded to the items that corresponded to the time-period in which they primarily 
cared for the participant. Items from the remaining time-period were completed by an additional 
informant who primarily cared for the participant during that time-period. The SLEEPY is 
administered in an interview (masters level psychologist), interviewee (direct care staff) format. 
If the participant had been selected for the inter-informant reliability sample, an additional 
SLEEPY was administered to another informant. If the participant had been selected for the test-
retest reliability sample, the same interviewer administered an additional SLEEPY to the same 
informant following a 1-2 week interval.
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Factor Analysis
Factor analysis is commonly used in scale development as a means to construct 
subscales. This procedure serves to simplify data by grouping together variables that are related 
to one another. Factor analysis is a useful procedure for summarizing information obtained from 
individual variables. While a useful tool, this procedure may not be appropriate or useful in all 
situations, as discussed by Guilford (1952). There are a number of issues to bear in mind when 
considering a factor analysis, among these are the minimum sample size needed, how many 
factors to extract, and which extraction method is to be used. 
For the present study, a total sample size of 400 was used. The SLEEPY consists of an 
initial item pool of 72 items, many of which sample the same domain. While this ratio (5.5:1) is 
sufficient to meet the minimum criteria set by a number of researchers (e.g. Gorsuch, 1983), the 
expected factor correlations were unknown, and thus the stability of the factor solution may be 
compromised. However, as the SLEEPY underwent an item analysis to remove unreliable or 
unendorsed items prior to the factor analysis, the ratio of participants to items was much higher 
than the 5:1 guideline.
For the exploratory factor analysis, the number of components to retain was determined 
by computing a parallel analysis. Following the parallel analysis, an exploratory principal 
components analysis was conducted, setting the number of factors to extract to that determined 
by the parallel analysis. Items were assigned to the factor with the greatest loading. To be 
included in a subscale, item loadings had to be above 0.4 (Gorsuch, 1983).
As the staff at PDC typically serve more than one individual at a time, it was expected 
that the same person may have served as an informant for more than one questionnaire. It may be 
argued that questionnaires using the same informant may not be sufficiently independent to 
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appropriately run a factor analysis. A lack of independence poses the potential to introduce 
systematic bias into the results of the analysis. Further, without examination, the stability of the 
factor solution may not be assumed (Gorsuch, 1983). To evaluate for a lack of independence and 
to evaluate the replicability of the factor structure found by the exploratory analysis, a second 
exploratory analysis was conducted. For the second exploratory analysis, only one questionnaire 
per informant was used. The second exploratory analyses included 201 completed 
questionnaires. 
Construct Validity
In establishing the validity of a measure, it is important to show that it both measures the 
intended construct as well as not measuring unintended constructs. This is known as convergent 
and discriminant validity (Anastasi & Urbina, 1997; Campbell & Fiske, 1959). The multi-trait 
multi-method system as described by Campbell and Fiske (1959) is difficult to conduct 
concerning a measure such as the SLEEPY. While an appropriate comparison measure, the 
DASH-II, has been developed, the broad scope of this measure may limit comparisons to the 
SLEEPY. Second, because of the widespread effect that sleep problems may have on the 
functioning of an individual, a variety of domains may be related to elevations on the subscales 
of the SLEEPY. Thus domains that traditionally conceptualized as unrelated such as autistic 
behavior may indeed have sleep problems as significant predictors (Schreck, Mulick, & Smith, 
2004). Further, as discussed earlier, sleep problems may significantly impact depression, anxiety, 
and challenging behaviors (Brylewski & Wiggs, 1999; Didden et al., 2002). Because of this 
widespread impact, it is difficult to suggest which domains should not be related to sleep 
problems, indeed, to do so may be premature considering the available literature. 
48
To evaluate the validity of the SLEEPY, responses to the DASH-II sleep items were 
compared to the corresponding SLEEPY items. Pearson product-moment correlations were 
computed between the subscales and corresponding items on the SLEEPY with the DASH-II 
sleep items.
 In order to evaluate the predictive validity of the SLEEPY, responses to SLEEPY items 
were compared directly to behavioral observations. Participants were classified into categories 
for each relevant item of the SLEEPY. Scores of 0 were classified as “No”, 1 as “Maybe”, and 2 
as “Yes”.  These classifications were then compared to the corresponding data from the sleep log 
observations. For the sleep log groups, participants were classified in regards to if they had been 
observed engaging in the corresponding target behavior. Correct and incorrect classification rates 
were then computed for each relevant item of the SLEEPY.
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RESULTS
Item Analysis
Each item on the SLEEPY was evaluated for overall variance of responses. Clark and 
Watson (1995) recommend the elimination of items in which virtually all of the respondents 
endorse or deny. In an overview of the development process of measures of this nature, Hagino 
(2002) reports that the cut-off of 80 percent is commonly used. However, Clark and Watson 
(1995) give the guideline of 95 percent. For the present study, any item that 90 percent or more 
of the informants answered “no” to was removed from the final questionnaire prior to the factor 
analysis. A total of 26 items were removed due to low endorsement. The items removed due to 
low variance are listed in Table 4. 
While item elimination due to low endorsement is important to streamline assessment and 
reduce unstable correlations (Comrey, 1978), it is important not to eliminate construct-relevant 
items even when endorsement is low (Clark & Watson, 1995). This is particularly the case when 
the expected base-rate of the construct is low.  Four items fell within this category in that they 
met the 90 percent or more criteria for removal but were not removed due to clinical importance 
and expected low base-rate of “yes” responses. These items include:  44. Has trouble breathing 
while sleeping, 57. Stops breathing while sleeping, 65. Gags or chokes while sleeping, and 68. 
Awakens during the night gasping for breath. 
Table 4
Items Removed Due to Low Variance
SLEEPY Item % “No”
3. Complains of headaches in the morning 97
24. Smokes cigarettes before going to bed 98
(Table 4 continued)
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30. Complains of loud noises during the night 97
31. Uses tobacco before going to bed 97
32. Complains of light disturbing sleep 98
33. Complains of others disturbing him/her while sleeping 95
34. Complains that the bedroom is too hot/cold 97
35. Eats a large snack before bed 91
41. Cries during the night 94
45. Sleeps in another’s bed 99
46. Does not want to sleep in his/her own bed 98
48. Sleepwalks 100
49. Talks while sleeping 98
52. Is afraid of noises at night 98
53. Is afraid to fall asleep 99
55. Requires medication to fall asleep 98
56. Sleeps poorly without medication 97
60. Rocks himself/herself to sleep 93
61. Awakens complaining of nightmares 99
62. Has a lengthy bedtime routine 95
64. Requires medication to sleep through the whole night 98
66. Has difficulty falling back to sleep when awoken during the night 91
69. Moves legs while sleeping 91
70. Moves arms while sleeping 92
71. Makes loud noises while sleeping 95
72. Has roommate who snores loudly 90
Item Test-Retest Reliability
Items were further evaluated for stability over time. Pearson product-moment correlation 
coefficients were computed for each SLEEPY item between administrations for the test-retest 
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sample. Items with coefficients below 0.5 were removed from the questionnaire before the factor 
analysis. A total of 15 items were removed due to low correlation coefficients. The items 
removed due to poor reliability are listed in Table 5. 
Table 5
Items Removed due to Reliability Below 0.5
SLEEPY Item r
9. Is sluggish when awoken .428
12. Difficult to awaken in the morning .390
20. Goes to bed earlier than his/her peers .338
22. Sleeps more than 10 hours a day .417
26. Drinks caffeinated beverages within 4 hours of bedtime .350
38. Snores loudly .349
39. Wakes up frequently during the night .449
42. Has difficulty relaxing before bed .457
43. Yells during the night .398
47. Grinds teeth while sleeping .248
51. Has difficulty relaxing at night .435
54. Awakens during the middle of the night .467
63. Awakens shortly after falling asleep .372
65. Gags or chokes while sleeping -.018
67. Does not keep a regular sleep schedule .220
In reviewing the remaining items, it was noted that the majority of the items written to 
address environmental factors that could cause or exacerbate sleep problems had been removed 
during the previous two steps of item analysis. Thus, it was decided to remove the remaining 
items designed to address environmental factors. In total, 5 items were removed for this reason. 
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These items include:  6. The bedroom is brightly lit before he/she awakes, 21. Sleeps with night-
light, 27. Gets woken up by noise, 28. Bedroom is noisy while he/she is sleeping, 29. Sleeps with 
room lights on. Following the item elimination, a total of 26 items remained.
Factor Analysis
To determine the number of components for the factor analysis, a parallel analysis was 
conducted. However, this is not a standard analysis available in the most popular statistical 
programs (SPSS & SAS). Fortunately, O’Connor (2000) provides the SPSS syntax necessary to 
conduct this analysis. The syntax may also be downloaded from the following internet address: 
http://flash.lakeheadu.ca/~boconno2/nfactors.html. Results of the parallel analysis indicated that 
a 4-factor model was the most appropriate. 
An exploratory factor analysis was conducted using SLEEPY item scores for the total 
sample of 400 participants. A principal components analysis with varimax rotation and holding 
the number of factors to 4 as determined by the parallel analysis (O’Connor, 2000) accounted for 
43.8% of the observed variance. A secondary principal components analysis using promax 
rotation found the same factor structure as the initial analysis that used varimax rotation, 
indicating that the factors are likely orthogonal (Gorsuch, 1983). 
Items were assigned to the factor with the greatest loading. However, item 19 was not 
assigned to a factor due to an undifferentiated pattern of loading (Gorsuch, 1983). Likewise, item 
40 was not assigned to a factor due to failure to meet the minimum loading of .4. Items 10, 15, 
and 16 did not meet the minimum criteria of .4 to be assigned to a factor. However, as their 
factor loading approached this level and met the commonly used but less stringent criteria for 
factor loadings of .3 (e.g. Schreck, Mulick, & Rojahn, 2003) as well as considering that the item 
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content matched the apparent theme of the factor, they were interpreted as meaningful to their 
respective factor (Gorsuch, 1983). See table 6 for specific factor loadings.
From viewing table 6, it is evident that Items that loaded on the first factor primarily 
consisted of daytime somnolence such as taking naps during the day, falling asleep at least once 
during the day and appearing drowsy during the day. Thus, the first factor was titled “Daytime 
Somnolence”. The second factor has the highest loadings with items concerning lack of sleep, 
nighttime wakening, arising extremely early in the morning, and getting out of bed during the 
night. Thus, factor two was titled “Sleep Maintenance”. Items loading on the third factor 
consisted of problems with waking-up and sleeping longer then others. Thus the third factor was 
titled “Hypersomnia”. Items loading on the fourth factor were concerned exclusively with 
breathing related sleep problems, thus this factor was titled “Breathing Related Sleep Problems”.
Table 6
Factor Loadings and Percent Variance for Exploratory Analysis
Factor 1: Daytime Somnolence (17.5%)
Item # Item Factor Loading
1 Takes naps during the day .757
2 Falls asleep when bored .798
4 Will fall asleep if not otherwise occupied .741
7 Appears sleepy during the day .686
8 Falls asleep at least once during the day .824
14 Appears drowsy during the day .644
15 Is inactive during the day .388
Factor 2: Sleep Maintenance (11.9%)
Item # Item Factor Loading
17 Awakens extremely early in the morning .681
18 Gets out of bed early .738
23 Sleeps less than 6 hours a day .479
25 Is very active before bedtime .452
36 Wakes up frequently to go to the bathroom .364
37 Drinks fluids before going to sleep .393
50 Disrupts other’s sleep .519
58 Repeatedly gets out of bed .702
59 Refuses to go to bed .579
(Table 6 continued)
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Factor 3: Hypersomnia (7.7%)
Item # Item Factor Loading
5 Gets out of bed later than his/her peers .671
10 Is disoriented (confused) when awoken .437
11 Wakes up looking tired .557
13 Sleeps longer than most of his/her peers .701
16 Is irritable during the day .361
Factor 4: Breathing Related Sleep Problems (6.8%)
Item # Item Factor Loading
44 Has trouble breathing while asleep .738
57 Stops breathing during sleep .867
68 Awakes during the night gasping for breath .819
In an effort to evaluate the stability of the factor structure, a second exploratory analysis 
was conducted. For this analysis, one questionnaire was randomly selected from each informant, 
such that, only one questionnaire per informant was used. The total number of participants for 
this analysis was 201. Table 7 presents the factor loadings.
Table 7
Factor Loadings and Percent Variance for Second Exploratory Analysis
Factor 1: Daytime Somnolence (17.3%)
Item # Item Factor Loading
1 Takes naps during the day .760
2 Falls asleep when bored .781
4 Will fall asleep if not otherwise occupied .732
7 Appears sleepy during the day .632
8 Falls asleep at least once during the day .838
10 Is disoriented (confused) when awoken .416
14 Appears drowsy during the day .630
Factor 2: Sleep Maintenance (11.8%)
Item # Item Factor Loading
17 Awakens extremely early in the morning .677
18 Gets out of bed early .750
23 Sleeps less than 6 hours a day .528
25 Is very active before bedtime .429
36 Wakes up frequently to go to the bathroom .392
37 Drinks fluids before going to sleep .363
50 Disrupts other’s sleep .438
58 Repeatedly gets out of bed .698
59 Refuses to go to bed .504
(Table 7 continued)
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Factor 3: Breathing Related Sleep Problems (6.2%)
Item # Item Factor Loading
44 Has trouble breathing while asleep .763
57 Stops breathing during sleep .896
68 Awakes during the night gasping for breath .829
Factor 4: Hypersomnia (8.2%)
Item # Item Factor Loading
5 Gets out of bed later than his/her peers .707
13 Sleeps longer than most of his/her peers .760
15 Is inactive during the day .435
16 Is irritable during the day .380
Subscale Inter-Rater Reliability
20 percent of the overall sample of participants were selected to receive a second 
administration of the SLEEPY using a different staff member as the informant. Pearson product-
moment correlations were conducted among SLEEPY subscale and total scores for each 
administration. Overall, correlations between informants were moderate. Due to a lack of 
variance on the BRSP subscale among the participants chosen for the inter-rater sample, a 
reliability coefficient was unable to be computed. Results of subscale correlations between 
informants are presented in table 8. 
Table 8
SLEEPY Subscale Inter-Rater Reliability Correlation Coefficients
Subscale r p-value
Factor 1:Daytime Somnolence .568 <0.000
Factor2: Sleep Maintenance .527 <0.000
Factor 3: Hypersomnia .729 <0.000
Factor 4: BRSP NA NA
Total Score .725 <0.000
Subscale Test-Retest Reliability
To assess for consistency of informant responses to SLEEPY items over time, 20% of the 
overall sample received a second administration of the SLEEPY with the same informant 
following a one to two week interval. Pearson product-moment correlations were computed for 
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each subscale and the total score between each administration. Correlations were again moderate. 
Results of subscale and total score correlations between administrations are presented in table 9
Table 9
SLEEPY Subscale Test-Retest Reliability Correlation Coefficients.
Subscale r p-value
Factor 1:Daytime Somnolence .744 <0.000
Factor2: Sleep Maintenance .636 <0.000
Factor 3: Hypersomnia .731 <0.000
Factor 4: BRSP .779 <0.000
Total Score .732 <0.000
Validity
To evaluate the validity of the SLEEPY, Pearson product moment correlations were 
computed between the subscales of the SLEEPY and the sleep scale items of the DASH-II. 
Further, the SLEEPY total score was correlated with the DASH-II sleep scale items. Due to lack 
of variance among responses to the DASH-II item “sleepwalks”, the correlation coefficient was 
not computed. Results of item correlations between DASH-II sleep scale items and SLEEPY 
subscales are presented in table 10.
Table 10
Pearson Product Moment Correlation Coefficients for DASH-II Items and corresponding 
SLEEPY Subscales.
DASH-II Item SLEEPY Subscale r p-value
14. Has difficulty staying awake 
during the day.
Daytime Somnolence 0.574 <0.000
19. Wakes up frequently during the 
night.
Sleep Maintenance .414 <0.000
39. Has difficulty getting to sleep. Sleep Maintenance .268 <0.000
79. Wakes up crying or screaming. Sleep Maintenance .181 <0.000
14. Has difficulty staying awake 
during the day.
Total Score .475 <0.000
19. Wakes up frequently during the 
night.
Total Score .372 <0.000
39. Has difficulty getting to sleep. Total Score .140 <0.000
79. Wakes up crying or screaming. Total Score .186 <0.000
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In order to evaluate the predictive validity of the SLEEPY, responses to SLEEPY items 
were compared directly to behavioral observations. Table 11 presents the classification of 
individual SLEEPY items compared to behavioral observations. Results are reported in regards 
to the number and percent of participants classified by each method.
Table 11
Classification rates for SLEEPY items Compared to Behavioral Observation
Observed asleep during the day
SLEEPY Item 1 No Yes
No 11 (61%) 1 (9%)Takes naps during the day
Yes 2 (11%) 5 (45%)
Maybe 5 (28%) 5 (45%)
Observed asleep during the day
SLEEPY Item 2 No Yes
No 10 (56%) 6 (54%)Falls asleep when bored
Yes 1 (6%) 5 (45%)
Maybe 7 (39%) 0 (0%)
Observed asleep during the day
SLEEPY Item 4 No Yes
No 11 (61%) 4 (36%)Will fall asleep if not otherwise occupied
Yes 1 (6%) 5 (45%)
Maybe 6 (33%) 2 (18%)
Out of bed after wake-up
SLEEPY Item 5 No Yes
No 25 (96%) 2 (67%)Gets out of bed later than his/her peers
Yes 1 (4%) 0 (0%)
Maybe 0 (0%) 1 (33%)
Observed asleep during the day
SLEEPY Item 8 No Yes
No 7 (39%) 3 (27%)Falls asleep at least once during the day
Yes 4 (22%) 6 (55%)
Maybe 7 (39%) 2 (18%)
Out of bed before wake-up
SLEEPY Item 17 No Yes
No 17 (71%) 5 (100%)Awakens extremely early in the morning
Yes 0 (0%) 0 (0%)
Maybe 7 (29%) 0 (0%)
(Table 11 continued)
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Out of bed before wake-up
SLEEPY Item 18 No Yes
No 17 (71%) 5 (100%)Gets out of bed early
Yes 1 (4%) 0 (0%)
Maybe 6 (25%) 0 (0%)
Less than 6 hours of sleep
SLEEPY Item 23 No Yes
No 23 (88%) 2 (67%)Sleeps less than 6 hours a day
Yes 0 (0%) 0 (0%)
Maybe 3 (12%) 1 (33%)
Snored during the observation
SLEEPY Item 44 No Yes
No 16 (89%) 11 (100%)Has trouble breathing while asleep
Yes 1 (6%) 0 (0%)
Maybe 1 (6%) 0 (0%)
Observed out of bed during night
SLEEPY Item 58 No Yes
No 15 (75%) 5 (56%)Repeatedly gets out of bed
Yes 1 (5%) 1 (11%)
Maybe 4 (20%) 3 (33%)
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DISCUSSION
A major limitation in understanding sleep problems in persons with developmental 
disabilities is the relative lack of reliable and valid assessment tools (Didden & Sigafoos, 2001; 
Johnson, 1996). The present study was an initial effort to develop a tool for the identification of 
sleep problems in persons with developmental disabilities. As a part of this process, the 
psychometric properties of the SLEEPY were examined. In particular, the factor structure, inter-
rater reliability, test-retest reliability, and construct validity of the SLEEPY were evaluated. 
Based upon the results of these analyses, the following conclusions are available. 
Factor Structure
An exploratory factor analysis of the SLEEPY using varimax rotation yielded a 4-factor 
solution. Twenty-four items were grouped into the following factors (1) Daytime Somnolence, 
(2) Sleep Maintenance, (3) Hypersomnia, and (4) Breathing Related Sleep Problems. These 
factors address four primary areas in which sleep problems may occur. The purpose in 
developing this instrument was to provide a means to rapidly assess individuals with 
developmental disabilities for sleep problems. By providing information concerning these 
specific domains in which sleep problems may occur, the SLEEPY may meet this purpose and 
allow clinicians to more quickly determine the area in which to invest more robust but costly 
assessment methods.
A second exploratory factor analysis was conducted using only one questionnaire per 
informant to evaluate the stability of the factor structure. Overall, the factors showed good 
stability. However, three items changed in their factor loadings. Item 10, which was originally 
assigned to the Hypersomnia subscale, loaded higher on the Daytime Somnolence subscale. 
Likewise, item 15, which loaded highest on the Daytime Somnolence subscale for the 
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exploratory analysis loaded highest on the Hypersomnia subscale on the second exploratory 
analysis.  Further, item 11, which was assigned to the Hypersomnia subscale by the exploratory 
analysis loaded on too many factors to warrant assignment to any particular factor found by the 
second exploratory analysis. 
While the overall factor structure of the SLEEPY did not significantly change between 
analyses, the instability of these three items is cause for some concern. It is noteworthy that items 
10 and 15 did not meet the criteria of factor loadings above .4 but were retained due to apparent 
homogeneity with the theme of the factor and because they met the less stringent criteria of 
similar measures (Schreck et al., 2003). The decision to retain these items may have been an 
error. However, the instability of the factor loadings for these three items may have been a result 
of an insufficient sample size for the second exploratory principal components analysis 
(DeVellis, 1991). Future confirmatory principal component analyses on independent 
administrations of the SLEEPY should help to clarify this issue.
Reliability
Inter-rater reliability coefficients for the SLEEPY total score and subscales fell within the 
moderate range. While reliability coefficients were not as robust as one might hope, results 
suggest that informants may reliably report on the day-to-day sleep behavior of the participants 
for the total score and the Hypersomnia subscale. The Daytime Somnolence and Sleep 
Maintenance scales showed moderate inter-rater reliability. From these data, it is evident that the 
person chosen to serve as an informant on the SLEEPY may significantly impact an individual’s 
Daytime Somnolence and Sleep Maintenance scores. As the individuals who live at PDC are 
primarily cared for by one person per shift, the secondary informant was most likely less 
informed about the participant’s day-to-day behavior than the primary care provider. While 
61
criteria were in place to control for the reduced familiarity of the secondary informants with the 
participant, the assumption that another informant whose duties focus on other individuals would 
be familiar enough to serve as a knowledgeable informant may have been wrong. Regardless of 
the source of error, the Daytime Somnolence and Sleep Maintenance subscales should be 
interpreted cautiously and care should be used to insure that informants are adequately familiar 
with the individual’s day-to-day behavior.
Test-retest reliability coefficients also fell in the moderate range, suggesting that while 
they may be susceptible to some variation across a one to two week period, informant responses 
are fairly stable over time. It is questionable if the difference observed between administrations 
is true variance or not. While it is presumed that sleep problems will be fairly stable across a 
two-week period, the lack of studies evaluating sleep problems in persons with developmental 
disabilities obscures our knowledge of what the true variance is. Thus, it is difficult to discern if 
the moderate correlations are a threat to the ability of the SLEEPY to reliably measure sleep 
problems over time. Further research is needed to clarify this issue. In particular, future studies 
using direct behavior observations across a number of weeks would help to clarify the issue of 
whether or not sleep problems are stable within this population.
Validity
The DASH-II sleep subscale consists of items that are worded and administered in the 
same manner as SLEEPY items. Most of the correlation coefficients, while statistically 
significant, were in the low range. It may be the case that for some items, the questions were 
phrased in such a way that the informant might have perceived them differently (i.e. DASH-II 
item 14. “Has difficulty staying awake during the day” and SLEEPY item 4.” Will fall asleep if 
not otherwise occupied”). Another explanation for this relatively low correlation coefficient may 
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be the period of time that is queried by the different measures. For items on the SLEEPY, the 
informant is instructed to consider the past month and then is asked to rate how accurate the 
statement is. Whereas the DASH-II instructs informants to consider the past two-weeks and to 
rate how frequently the behavior has occurred. The different criteria will result in the DASH-II 
having a smaller window in which the sleep problem may have occurred. Further, the DASH-II 
instructs informants to report the frequency of the behavior. In contrast, the SLEEPY items ask 
the informant to respond concerning the accuracy of the statement. These two methods differ 
significantly. One method relies upon recall of behavior while the other relies upon the 
informants overall perception of behavior. Informants responding to the DASH-II items reported 
fewer sleep problems than they did on the SLEEPY items. The lower rate of endorsement on the 
DASH-II may be due to informants’ inability to recall specific occurrences or apprehension of 
over endorsement. 
Classification decisions using SLEEPY item scores were compared to classifications 
made using direct observations over a period of 24 hours. The classification rates of the SLEEPY 
can be interpreted in regards to type 1 and type 2 errors, that is, rejecting the null hypothesis 
when it is true (type 1) and retaining the null hypothesis when it is false (type 2). Overall, the 
SLEEPY showed very low rates of false positives. However, the occurrence of false negatives 
was much higher. Thus, individual SLEEPY items showed good specificity when compared to 
behavioral observations but questionable sensitivity. 
Regarding specific behavioral observations, the sleep log data “observed asleep during 
the day” corresponded to the following SLEEPY items: 1. takes naps during the day, 2. Falls 
asleep when bored, and 4. Will fall asleep if not otherwise occupied. The most generally worded 
of these items, number 1, showed the highest sensitivity, falsely rejecting only 9% of those 
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individuals who were observed sleeping during the day. However, the more specifically worded, 
items of 2, 4, and 8, showed poorer sensitivity, falsely rejecting 54, 36, and 27% of those 
individual’s who were observed sleeping during the day. It is likely that staff are unsure of the 
particular cause for napping during the day such as boredom or lack of activities and thus are 
reluctant to answer in the affirmative to specific causes.
Concerning the observation of “not out of bed after wake-up”, three individuals were 
observed to not be out of bed. Of these three participants, item 5 misclassified two as not having 
problems with getting out of bed later than their peers. Similar to the observation “not out of bed 
after wake-up” the behavior observation “out of bed before wake-up” showed poor 
correspondence with SLEEPY items 17 and 18. Five participants were observed to get out of bed 
before the morning staff woke-up their peers. Of these five, items 17 and 18 misclassified 100% 
as not having problems with awakening early in the morning and getting out of bed early. One 
explanation for this poor sensitivity is that daytime staff may not arrive early enough to answer 
these items accurately. Awaking and helping the residents to get ready in the morning are among 
the final duties of the night staff at PDC. Thus, the daytime staff should not be informants for 
items 17 and 18. 
The SLEEPY item 44 “has trouble breathing while sleeping” showed poor sensitivity 
when compared to the number of participants who were observed snoring during the behavior 
observations. Eleven participants were observed snoring for at least one interval throughout the 
24-hour observation. Informants responded “no” on item 44 for all eleven of these participants. It 
may be the case that the informants did not consider snoring as troubled breathing. Considering 
that item 38 “snores loudly” was removed due to poor reliability, it is questionable if phrasing 
item 44 to more specifically match the observation of snoring would improve the sensitivity. 
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Further, Hoffstein and Szalai (1993) reported that clinicians who commonly see patients with 
sleep problems showed poor sensitivity to breathing related sleep problems. Thus, it should not 
be surprising informants in the current study, who were not trained in the diagnosis of sleep 
problems, also showed poor sensitivity.
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CONCLUSION
The SLEEPY was designed as a measure to efficiently assess for sleep problems in 
persons with developmental disabilities. This initial effort presents data on the factor structure, 
reliability, and validity of the SLEEPY. The factor structure of the SLEEPY resulted in four 
domains of sleep problems. The same factors were found by a second exploratory principal 
components analysis. While three items changed in regards to their factor loadings, the overall 
factor structure of the SLEEPY appeared stable. Adequate inter-rater reliability was shown for 
the Hypersomnia and BRSP subscales of the SLEEPY. Likewise, the total score showed 
adequate inter-rater reliability, indicating that informants generally agreed on the overall level of 
sleep problems in participants. However, the Daytime Somnolence and Sleep Maintenance 
subscales showed questionable reliability. Thus, care should be used in selecting appropriate 
informants. To meet this need, future research should evaluate which characteristics are 
important when considering what constitutes a qualified informant.
Adequate test-retest reliability was found for all of the subscales and the total score of the 
SLEEPY. Thus, they showed adequate stability for their ratings of sleep problems over time. 
Multiple-week objective monitoring (such as behavior observations, actigraphy or PSG) of sleep 
problems should help elucidate the true variability of sleep problems among persons with 
developmental disabilities. Future test-retest reliability evaluations should be interpreted in light 
of any new findings.
Evaluation of the validity of the SLEEPY showed mixed results. Comparisons to direct 
behavioral observations found SLEEPY items to have excellent specificity but low sensitivity to 
sleep problems. It is worth noting that the informants under-reported sleep problems rather than 
over-reported. The low sensitivity of the SLEEPY may reflect the degree to which direct care 
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staff were aware of the less overt sleep behaviors of the participants. Behaviors of long duration 
such as daytime napping showed better classification rates than other behaviors such as snoring, 
which may occur covertly and only be notice by direct care staff if they happen to check-in on 
the individual at that point in time. Indeed, in a study on the relationships between sleep 
organization, sleep disorders and epilepsy, Bruni, Cortesi, Giannotti, and Curatolo (1995) found 
that parents missed a high number of brief awakenings relative to PSG.
While the present study found low sensitivity for the SLEEPY to detect sleep problems as 
measured by behavior observations, results are similar to those reported by Espie et al. (1998) 
who compared caregiver reports of sleep in sleep-diaries to EEG. Espie et al. (1998) found 
caregiver report to over-estimate sleep length by approximately 1 hour. Further, the only 
caregiver variable that predicted the participants’ as appearing “refreshed” upon awakening was 
an early bedtime, not the number of nighttime awakenings or sleep latency. Thus in both the 
present study and the results reported by Espie et al. (1998) and Bruni et al. (1995), caregiver 
report was found to under-report sleep problems but to be significantly related to objective 
measures of sleep.
The present results concerning informant-report of sleep problems are interesting when 
compared to findings concerning self-reported sleep problems. Self-reported sleep diaries 
typically overestimate sleep problems in relation to objective measures of sleep (Tyron, 2004). 
When using caregivers to report on sleep problems, the opposite trend occurs and sleep problems 
are underreported relative to objective measures (Espie et al., 1998). It is likely that the low 
sensitivity of the SLEEPY when compared to behavior observations is due to the caregiver’s 
tendency to underestimate sleep problems. Perhaps with caregiver training to attend to more 
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sleep related variables as well as coaching to lower the informant’s threshold for what constitutes 
problem sleep may increase the sensitivity of the SLEEPY.
Informant based questionnaires offer rapid and less costly means to assess for sleep 
problems in persons with developmental disabilities. However, indirect assessments  are often 
less valid than direct observations (Johnston & Pennypacker, 1993). The utility of informant 
based questionnaires is dependent upon the reliability of the informants used to answer items 
(Smith, et al., 2003). The present study assessed the psychometric properties of the SLEEPY 
using participants from a large developmental center in Louisiana. Further research is needed to 
evaluate the psychometric properties of the SLEEPY using different informant populations. For 
example, it is likely that parents who live with their child with developmental disabilities would 
have a much better understanding of their child’s daily behavior, particularly in light of their 
exposure to their child on a 24-hour basis.
On the whole, these data are promising. The results of the present study indicate that 
further studies evaluating the reliability and validity of the SLEEPY are warranted. The most 
significant limitation of the SLEEPY appears to center on the degree to which informants may 
reliably and accurately report on various sleep problems. This issue should be the primary focus 
of future research.
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